#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Social affective context reveals altered network dynamics in schizophrenia patients Impairments in social cognition and interactions are core psychopathologies in schizophrenia, often manifesting as an inability to appropriately relate to the intentions and feelings of others.
1-1	0-6	Social	_
1-2	7-16	affective	_
1-3	17-24	context	_
1-4	25-32	reveals	_
1-5	33-40	altered	_
1-6	41-48	network	_
1-7	49-57	dynamics	_
1-8	58-60	in	_
1-9	61-74	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-10	75-83	patients	_
1-11	84-95	Impairments	_
1-12	96-98	in	_
1-13	99-105	social	_
1-14	106-115	cognition	_
1-15	116-119	and	_
1-16	120-132	interactions	_
1-17	133-136	are	_
1-18	137-141	core	_
1-19	142-159	psychopathologies	_
1-20	160-162	in	_
1-21	163-176	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-22	177-178	,	_
1-23	179-184	often	_
1-24	185-196	manifesting	_
1-25	197-199	as	_
1-26	200-202	an	_
1-27	203-212	inability	_
1-28	213-215	to	_
1-29	216-229	appropriately	_
1-30	230-236	relate	_
1-31	237-239	to	_
1-32	240-243	the	_
1-33	244-254	intentions	_
1-34	255-258	and	_
1-35	259-267	feelings	_
1-36	268-270	of	_
1-37	271-277	others	_
1-38	278-279	.	_

Text=Neuroimaging has helped to demarcate the dynamics of two distinct functional connectivity circuits underlying the social-affective processes related to mentalization (known as Theory of Mind, ToM) and somatic-affiliation (known as Embodied Simulation, ES).
2-1	280-292	Neuroimaging	_
2-2	293-296	has	_
2-3	297-303	helped	_
2-4	304-306	to	_
2-5	307-316	demarcate	_
2-6	317-320	the	_
2-7	321-329	dynamics	_
2-8	330-332	of	_
2-9	333-336	two	_
2-10	337-345	distinct	_
2-11	346-356	functional	_
2-12	357-369	connectivity	_
2-13	370-378	circuits	_
2-14	379-389	underlying	_
2-15	390-393	the	_
2-16	394-410	social-affective	_
2-17	411-420	processes	_
2-18	421-428	related	_
2-19	429-431	to	_
2-20	432-445	mentalization	_
2-21	446-447	(	_
2-22	448-453	known	_
2-23	454-456	as	_
2-24	457-463	Theory	_
2-25	464-466	of	_
2-26	467-471	Mind	_
2-27	472-473	,	_
2-28	474-477	ToM	_
2-29	478-479	)	_
2-30	480-483	and	_
2-31	484-503	somatic-affiliation	_
2-32	504-505	(	_
2-33	506-511	known	_
2-34	512-514	as	_
2-35	515-523	Embodied	_
2-36	524-534	Simulation	_
2-37	535-536	,	_
2-38	537-539	ES	_
2-39	540-541	)	_
2-40	542-543	.	_

Text=While evidence points to abnormal activation patterns within these networks among those suffering from schizophrenia, it is yet unclear however, if these patients exhibit this abnormal functional connectivity in the context of social-affective experiences.
3-1	544-549	While	_
3-2	550-558	evidence	_
3-3	559-565	points	_
3-4	566-568	to	_
3-5	569-577	abnormal	_
3-6	578-588	activation	_
3-7	589-597	patterns	_
3-8	598-604	within	_
3-9	605-610	these	_
3-10	611-619	networks	_
3-11	620-625	among	_
3-12	626-631	those	_
3-13	632-641	suffering	_
3-14	642-646	from	_
3-15	647-660	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-16	661-662	,	_
3-17	663-665	it	_
3-18	666-668	is	_
3-19	669-672	yet	_
3-20	673-680	unclear	_
3-21	681-688	however	_
3-22	689-690	,	_
3-23	691-693	if	_
3-24	694-699	these	_
3-25	700-708	patients	_
3-26	709-716	exhibit	_
3-27	717-721	this	_
3-28	722-730	abnormal	_
3-29	731-741	functional	_
3-30	742-754	connectivity	_
3-31	755-757	in	_
3-32	758-761	the	_
3-33	762-769	context	_
3-34	770-772	of	_
3-35	773-789	social-affective	_
3-36	790-801	experiences	_
3-37	802-803	.	_

Text=The current fMRI study, investigated functional connectivity dynamics within ToM and ES networks as subjects experienced evolving cinematic portrayals of fear.
4-1	804-807	The	_
4-2	808-815	current	_
4-3	816-820	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-4	821-826	study	_
4-5	827-828	,	_
4-6	829-841	investigated	_
4-7	842-852	functional	_
4-8	853-865	connectivity	_
4-9	866-874	dynamics	_
4-10	875-881	within	_
4-11	882-885	ToM	_
4-12	886-889	and	_
4-13	890-892	ES	_
4-14	893-901	networks	_
4-15	902-904	as	_
4-16	905-913	subjects	_
4-17	914-925	experienced	_
4-18	926-934	evolving	_
4-19	935-944	cinematic	_
4-20	945-955	portrayals	_
4-21	956-958	of	_
4-22	959-963	fear	_
4-23	964-965	.	_

Text=During scanning, schizophrenia patients and healthy controls passively watched a cinematic scene in which a mother and her son face various threatening events.
5-1	966-972	During	_
5-2	973-981	scanning	_
5-3	982-983	,	_
5-4	984-997	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-5	998-1006	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-6	1007-1010	and	_
5-7	1011-1018	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-8	1019-1027	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-9	1028-1037	passively	_
5-10	1038-1045	watched	_
5-11	1046-1047	a	_
5-12	1048-1057	cinematic	_
5-13	1058-1063	scene	_
5-14	1064-1066	in	_
5-15	1067-1072	which	_
5-16	1073-1074	a	_
5-17	1075-1081	mother	_
5-18	1082-1085	and	_
5-19	1086-1089	her	_
5-20	1090-1093	son	_
5-21	1094-1098	face	_
5-22	1099-1106	various	_
5-23	1107-1118	threatening	_
5-24	1119-1125	events	_
5-25	1126-1127	.	_

Text=Participants then provided a continuous and retrospective report of their fear intensity during a second viewing outside the scanner.
6-1	1128-1140	Participants	_
6-2	1141-1145	then	_
6-3	1146-1154	provided	_
6-4	1155-1156	a	_
6-5	1157-1167	continuous	_
6-6	1168-1171	and	_
6-7	1172-1185	retrospective	_
6-8	1186-1192	report	_
6-9	1193-1195	of	_
6-10	1196-1201	their	_
6-11	1202-1206	fear	_
6-12	1207-1216	intensity	_
6-13	1217-1223	during	_
6-14	1224-1225	a	_
6-15	1226-1232	second	_
6-16	1233-1240	viewing	_
6-17	1241-1248	outside	_
6-18	1249-1252	the	_
6-19	1253-1260	scanner	_
6-20	1261-1262	.	_

Text=Using network cohesion index (NCI) analysis, we examined modulations of ES-related and ToM-related functional connectivity dynamics and their relation to symptom severity and the continuous emotional ratings of the induced cinematic fear.
7-1	1263-1268	Using	_
7-2	1269-1276	network	_
7-3	1277-1285	cohesion	_
7-4	1286-1291	index	_
7-5	1292-1293	(	_
7-6	1294-1297	NCI	_
7-7	1298-1299	)	_
7-8	1300-1308	analysis	_
7-9	1309-1310	,	_
7-10	1311-1313	we	_
7-11	1314-1322	examined	_
7-12	1323-1334	modulations	_
7-13	1335-1337	of	_
7-14	1338-1348	ES-related	_
7-15	1349-1352	and	_
7-16	1353-1364	ToM-related	_
7-17	1365-1375	functional	_
7-18	1376-1388	connectivity	_
7-19	1389-1397	dynamics	_
7-20	1398-1401	and	_
7-21	1402-1407	their	_
7-22	1408-1416	relation	_
7-23	1417-1419	to	_
7-24	1420-1427	symptom	_
7-25	1428-1436	severity	_
7-26	1437-1440	and	_
7-27	1441-1444	the	_
7-28	1445-1455	continuous	_
7-29	1456-1465	emotional	_
7-30	1466-1473	ratings	_
7-31	1474-1476	of	_
7-32	1477-1480	the	_
7-33	1481-1488	induced	_
7-34	1489-1498	cinematic	_
7-35	1499-1503	fear	_
7-36	1504-1505	.	_

Text=Compared to patients, healthy controls showed higher ES-NCI and marginally lower ToM-NCI during emotional peaks.
8-1	1506-1514	Compared	_
8-2	1515-1517	to	_
8-3	1518-1526	patients	_
8-4	1527-1528	,	_
8-5	1529-1536	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
8-6	1537-1545	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
8-7	1546-1552	showed	_
8-8	1553-1559	higher	_
8-9	1560-1566	ES-NCI	http://maven.renci.org/NeuroBridge/neurobridge#ThyroidCancer
8-10	1567-1570	and	_
8-11	1571-1581	marginally	_
8-12	1582-1587	lower	_
8-13	1588-1595	ToM-NCI	_
8-14	1596-1602	during	_
8-15	1603-1612	emotional	_
8-16	1613-1618	peaks	_
8-17	1619-1620	.	_

Text=Cross-correlation analysis revealed an intriguing dynamic between NCI and the inter-group difference of reported fear.
9-1	1621-1638	Cross-correlation	_
9-2	1639-1647	analysis	_
9-3	1648-1656	revealed	_
9-4	1657-1659	an	_
9-5	1660-1670	intriguing	_
9-6	1671-1678	dynamic	_
9-7	1679-1686	between	_
9-8	1687-1690	NCI	_
9-9	1691-1694	and	_
9-10	1695-1698	the	_
9-11	1699-1710	inter-group	_
9-12	1711-1721	difference	_
9-13	1722-1724	of	_
9-14	1725-1733	reported	_
9-15	1734-1738	fear	_
9-16	1739-1740	.	_

Text=Schizophrenia patients rated their fear as lower relative to healthy controls, shortly after exhibiting lower ES connectivity.
10-1	1741-1754	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-2	1755-1763	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
10-3	1764-1769	rated	_
10-4	1770-1775	their	_
10-5	1776-1780	fear	_
10-6	1781-1783	as	_
10-7	1784-1789	lower	_
10-8	1790-1798	relative	_
10-9	1799-1801	to	_
10-10	1802-1809	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
10-11	1810-1818	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
10-12	1819-1820	,	_
10-13	1821-1828	shortly	_
10-14	1829-1834	after	_
10-15	1835-1845	exhibiting	_
10-16	1846-1851	lower	_
10-17	1852-1854	ES	_
10-18	1855-1867	connectivity	_
10-19	1868-1869	.	_

Text=This increased difference in rating was also followed by higher ToM connectivity among schizophrenia patients.
11-1	1870-1874	This	_
11-2	1875-1884	increased	_
11-3	1885-1895	difference	_
11-4	1896-1898	in	_
11-5	1899-1905	rating	_
11-6	1906-1909	was	_
11-7	1910-1914	also	_
11-8	1915-1923	followed	_
11-9	1924-1926	by	_
11-10	1927-1933	higher	_
11-11	1934-1937	ToM	_
11-12	1938-1950	connectivity	_
11-13	1951-1956	among	_
11-14	1957-1970	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-15	1971-1979	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-16	1980-1981	.	_

Text=The clinical relevance of these findings is further highlighted by the following two results: (a) ToM-NCI was found to have a strong correlation with the severity of general symptoms during one of the two main emotional peaks (Spearman R = 0.77); and (b) k-mean clustering demonstrated that the networks ’ NCI dynamic during the social-affective context reliably differentiated between patients and controls.
12-1	1982-1985	The	_
12-2	1986-1994	clinical	_
12-3	1995-2004	relevance	_
12-4	2005-2007	of	_
12-5	2008-2013	these	_
12-6	2014-2022	findings	_
12-7	2023-2025	is	_
12-8	2026-2033	further	_
12-9	2034-2045	highlighted	_
12-10	2046-2048	by	_
12-11	2049-2052	the	_
12-12	2053-2062	following	_
12-13	2063-2066	two	_
12-14	2067-2074	results	_
12-15	2075-2076	:	_
12-16	2077-2078	(	_
12-17	2079-2080	a	_
12-18	2081-2082	)	_
12-19	2083-2090	ToM-NCI	_
12-20	2091-2094	was	_
12-21	2095-2100	found	_
12-22	2101-2103	to	_
12-23	2104-2108	have	_
12-24	2109-2110	a	_
12-25	2111-2117	strong	_
12-26	2118-2129	correlation	_
12-27	2130-2134	with	_
12-28	2135-2138	the	_
12-29	2139-2147	severity	_
12-30	2148-2150	of	_
12-31	2151-2158	general	_
12-32	2159-2167	symptoms	_
12-33	2168-2174	during	_
12-34	2175-2178	one	_
12-35	2179-2181	of	_
12-36	2182-2185	the	_
12-37	2186-2189	two	_
12-38	2190-2194	main	_
12-39	2195-2204	emotional	_
12-40	2205-2210	peaks	_
12-41	2211-2212	(	_
12-42	2213-2221	Spearman	_
12-43	2222-2223	R	_
12-44	2224-2225	=	_
12-45	2226-2230	0.77	_
12-46	2231-2232	)	_
12-47	2233-2234	;	_
12-48	2235-2238	and	_
12-49	2239-2240	(	_
12-50	2241-2242	b	_
12-51	2243-2244	)	_
12-52	2245-2251	k-mean	_
12-53	2252-2262	clustering	_
12-54	2263-2275	demonstrated	_
12-55	2276-2280	that	_
12-56	2281-2284	the	_
12-57	2285-2293	networks	_
12-58	2294-2295	’	_
12-59	2296-2299	NCI	_
12-60	2300-2307	dynamic	_
12-61	2308-2314	during	_
12-62	2315-2318	the	_
12-63	2319-2335	social-affective	_
12-64	2336-2343	context	_
12-65	2344-2352	reliably	_
12-66	2353-2367	differentiated	_
12-67	2368-2375	between	_
12-68	2376-2384	patients	_
12-69	2385-2388	and	_
12-70	2389-2397	controls	_
12-71	2398-2399	.	_

Text=Together, these findings point to a possible neural marker for abnormal social-affective processing in schizophrenia, manifested as the disturbed balance between two functional networks involved in social-affective affiliation.
13-1	2400-2408	Together	_
13-2	2409-2410	,	_
13-3	2411-2416	these	_
13-4	2417-2425	findings	_
13-5	2426-2431	point	_
13-6	2432-2434	to	_
13-7	2435-2436	a	_
13-8	2437-2445	possible	_
13-9	2446-2452	neural	_
13-10	2453-2459	marker	_
13-11	2460-2463	for	_
13-12	2464-2472	abnormal	_
13-13	2473-2489	social-affective	_
13-14	2490-2500	processing	_
13-15	2501-2503	in	_
13-16	2504-2517	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-17	2518-2519	,	_
13-18	2520-2530	manifested	_
13-19	2531-2533	as	_
13-20	2534-2537	the	_
13-21	2538-2547	disturbed	_
13-22	2548-2555	balance	_
13-23	2556-2563	between	_
13-24	2564-2567	two	_
13-25	2568-2578	functional	_
13-26	2579-2587	networks	_
13-27	2588-2596	involved	_
13-28	2597-2599	in	_
13-29	2600-2616	social-affective	_
13-30	2617-2628	affiliation	_
13-31	2629-2630	.	_

Text=This in turn suggests that exaggerated mentalization over somatic-affiliative processing, in response to another ’ s ’ distress may underlie social-affective deficits in schizophrenia.
14-1	2631-2635	This	_
14-2	2636-2638	in	_
14-3	2639-2643	turn	_
14-4	2644-2652	suggests	_
14-5	2653-2657	that	_
14-6	2658-2669	exaggerated	_
14-7	2670-2683	mentalization	_
14-8	2684-2688	over	_
14-9	2689-2708	somatic-affiliative	_
14-10	2709-2719	processing	_
14-11	2720-2721	,	_
14-12	2722-2724	in	_
14-13	2725-2733	response	_
14-14	2734-2736	to	_
14-15	2737-2744	another	_
14-16	2745-2746	’	_
14-17	2747-2748	s	_
14-18	2749-2750	’	_
14-19	2751-2759	distress	_
14-20	2760-2763	may	_
14-21	2764-2772	underlie	_
14-22	2773-2789	social-affective	_
14-23	2790-2798	deficits	_
14-24	2799-2801	in	_
14-25	2802-2815	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
14-26	2816-2817	.	_

Text=Materials and methods Subjects The study groups included 30 inpatients (13 women; mean age 25, range: 18–40 years) recruited by a senior psychiatrists at one of three Mental Health Centers: Beer Yaakov Mental Health Center, Mazra Mental Health Center and Lev-Hasharon Mental Health Center.
15-1	2818-2827	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
15-2	2828-2831	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
15-3	2832-2839	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
15-4	2840-2848	Subjects	_
15-5	2849-2852	The	_
15-6	2853-2858	study	_
15-7	2859-2865	groups	_
15-8	2866-2874	included	_
15-9	2875-2877	30	_
15-10	2878-2888	inpatients	_
15-11	2889-2890	(	_
15-12	2891-2893	13	_
15-13	2894-2899	women	_
15-14	2900-2901	;	_
15-15	2902-2906	mean	_
15-16	2907-2910	age	_
15-17	2911-2913	25	_
15-18	2914-2915	,	_
15-19	2916-2921	range	_
15-20	2922-2923	:	_
15-21	2924-2929	18–40	_
15-22	2930-2935	years	_
15-23	2936-2937	)	_
15-24	2938-2947	recruited	_
15-25	2948-2950	by	_
15-26	2951-2952	a	_
15-27	2953-2959	senior	_
15-28	2960-2973	psychiatrists	_
15-29	2974-2976	at	_
15-30	2977-2980	one	_
15-31	2981-2983	of	_
15-32	2984-2989	three	_
15-33	2990-2996	Mental	_
15-34	2997-3003	Health	_
15-35	3004-3011	Centers	_
15-36	3012-3013	:	_
15-37	3014-3018	Beer	_
15-38	3019-3025	Yaakov	_
15-39	3026-3032	Mental	_
15-40	3033-3039	Health	_
15-41	3040-3046	Center	_
15-42	3047-3048	,	_
15-43	3049-3054	Mazra	_
15-44	3055-3061	Mental	_
15-45	3062-3068	Health	_
15-46	3069-3075	Center	_
15-47	3076-3079	and	_
15-48	3080-3092	Lev-Hasharon	_
15-49	3093-3099	Mental	_
15-50	3100-3106	Health	_
15-51	3107-3113	Center	_
15-52	3114-3115	.	_

Text=Patients were diagnosed based on the structured clinical interview for DSM-IV Axis-I disorders, Patient Edition, SCID-I/P (First, 1994), while hospitalized.
16-1	3116-3124	Patients	_
16-2	3125-3129	were	_
16-3	3130-3139	diagnosed	_
16-4	3140-3145	based	_
16-5	3146-3148	on	_
16-6	3149-3152	the	_
16-7	3153-3163	structured	_
16-8	3164-3172	clinical	_
16-9	3173-3182	interview	_
16-10	3183-3186	for	_
16-11	3187-3193	DSM-IV	_
16-12	3194-3200	Axis-I	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-13	3201-3210	disorders	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
16-14	3211-3212	,	_
16-15	3213-3220	Patient	_
16-16	3221-3228	Edition	_
16-17	3229-3230	,	_
16-18	3231-3239	SCID-I/P	_
16-19	3240-3241	(	_
16-20	3242-3247	First	_
16-21	3248-3249	,	_
16-22	3250-3254	1994	_
16-23	3255-3256	)	_
16-24	3257-3258	,	_
16-25	3259-3264	while	_
16-26	3265-3277	hospitalized	_
16-27	3278-3279	.	_

Text=Those with major affective or neurological disorders, or drug-induced or alcohol-induced psychoses were not included.
17-1	3280-3285	Those	_
17-2	3286-3290	with	_
17-3	3291-3296	major	_
17-4	3297-3306	affective	_
17-5	3307-3309	or	_
17-6	3310-3322	neurological	_
17-7	3323-3332	disorders	_
17-8	3333-3334	,	_
17-9	3335-3337	or	_
17-10	3338-3350	drug-induced	_
17-11	3351-3353	or	_
17-12	3354-3369	alcohol-induced	_
17-13	3370-3379	psychoses	_
17-14	3380-3384	were	_
17-15	3385-3388	not	_
17-16	3389-3397	included	_
17-17	3398-3399	.	_

Text=Medical and neurological illnesses were ruled out by physical and neurological examinations, routine laboratory investigations, reports from the patients ’ family physicians and the hospital medical records.
18-1	3400-3407	Medical	_
18-2	3408-3411	and	_
18-3	3412-3424	neurological	_
18-4	3425-3434	illnesses	_
18-5	3435-3439	were	_
18-6	3440-3445	ruled	_
18-7	3446-3449	out	_
18-8	3450-3452	by	_
18-9	3453-3461	physical	_
18-10	3462-3465	and	_
18-11	3466-3478	neurological	_
18-12	3479-3491	examinations	_
18-13	3492-3493	,	_
18-14	3494-3501	routine	_
18-15	3502-3512	laboratory	_
18-16	3513-3527	investigations	_
18-17	3528-3529	,	_
18-18	3530-3537	reports	_
18-19	3538-3542	from	_
18-20	3543-3546	the	_
18-21	3547-3555	patients	_
18-22	3556-3557	’	_
18-23	3558-3564	family	_
18-24	3565-3575	physicians	_
18-25	3576-3579	and	_
18-26	3580-3583	the	_
18-27	3584-3592	hospital	_
18-28	3593-3600	medical	_
18-29	3601-3608	records	_
18-30	3609-3610	.	_

Text=Severity of schizophrenia symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS) (Table S1).
19-1	3611-3619	Severity	_
19-2	3620-3622	of	_
19-3	3623-3636	schizophrenia	_
19-4	3637-3645	symptoms	_
19-5	3646-3650	were	_
19-6	3651-3659	assessed	_
19-7	3660-3664	with	_
19-8	3665-3668	the	_
19-9	3669-3677	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-10	3678-3681	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-11	3682-3690	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-12	3691-3699	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-13	3700-3705	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-14	3706-3707	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-15	3708-3713	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-16	3714-3715	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
19-17	3716-3717	(	_
19-18	3718-3723	Table	_
19-19	3724-3726	S1	_
19-20	3727-3728	)	_
19-21	3729-3730	.	_

Text=Twenty-three healthy individuals without any known psychiatric or neurologic disorder (12 women; mean age 26, 22–39 years) were recruited through public advertisement (Table S1).
20-1	3731-3743	Twenty-three	_
20-2	3744-3751	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-3	3752-3763	individuals	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-4	3764-3771	without	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-5	3772-3775	any	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-6	3776-3781	known	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-7	3782-3793	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-8	3794-3796	or	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-9	3797-3807	neurologic	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-10	3808-3816	disorder	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
20-11	3817-3818	(	_
20-12	3819-3821	12	_
20-13	3822-3827	women	_
20-14	3828-3829	;	_
20-15	3830-3834	mean	_
20-16	3835-3838	age	_
20-17	3839-3841	26	_
20-18	3842-3843	,	_
20-19	3844-3849	22–39	_
20-20	3850-3855	years	_
20-21	3856-3857	)	_
20-22	3858-3862	were	_
20-23	3863-3872	recruited	_
20-24	3873-3880	through	_
20-25	3881-3887	public	_
20-26	3888-3901	advertisement	_
20-27	3902-3903	(	_
20-28	3904-3909	Table	_
20-29	3910-3912	S1	_
20-30	3913-3914	)	_
20-31	3915-3916	.	_

Text=Patients and healthy controls were matched for age and gender.
21-1	3917-3925	Patients	_
21-2	3926-3929	and	_
21-3	3930-3937	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-4	3938-3946	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-5	3947-3951	were	_
21-6	3952-3959	matched	_
21-7	3960-3963	for	_
21-8	3964-3967	age	_
21-9	3968-3971	and	_
21-10	3972-3978	gender	_
21-11	3979-3980	.	_

Text=All participants were native Hebrew speakers with adequate language comprehension.
22-1	3981-3984	All	_
22-2	3985-3997	participants	_
22-3	3998-4002	were	_
22-4	4003-4009	native	_
22-5	4010-4016	Hebrew	_
22-6	4017-4025	speakers	_
22-7	4026-4030	with	_
22-8	4031-4039	adequate	_
22-9	4040-4048	language	_
22-10	4049-4062	comprehension	_
22-11	4063-4064	.	_

Text=After drop-out, due to motion artifacts (see below), our final sample included 27 patients (10 women; mean age 25, range: 18–40 years) and 22 healthy controls (11 female, mean age: 26, range: 22–39).
23-1	4065-4070	After	_
23-2	4071-4079	drop-out	_
23-3	4080-4081	,	_
23-4	4082-4085	due	_
23-5	4086-4088	to	_
23-6	4089-4095	motion	_
23-7	4096-4105	artifacts	_
23-8	4106-4107	(	_
23-9	4108-4111	see	_
23-10	4112-4117	below	_
23-11	4118-4119	)	_
23-12	4120-4121	,	_
23-13	4122-4125	our	_
23-14	4126-4131	final	_
23-15	4132-4138	sample	_
23-16	4139-4147	included	_
23-17	4148-4150	27	_
23-18	4151-4159	patients	_
23-19	4160-4161	(	_
23-20	4162-4164	10	_
23-21	4165-4170	women	_
23-22	4171-4172	;	_
23-23	4173-4177	mean	_
23-24	4178-4181	age	_
23-25	4182-4184	25	_
23-26	4185-4186	,	_
23-27	4187-4192	range	_
23-28	4193-4194	:	_
23-29	4195-4200	18–40	_
23-30	4201-4206	years	_
23-31	4207-4208	)	_
23-32	4209-4212	and	_
23-33	4213-4215	22	_
23-34	4216-4223	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-35	4224-4232	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-36	4233-4234	(	_
23-37	4235-4237	11	_
23-38	4238-4244	female	_
23-39	4245-4246	,	_
23-40	4247-4251	mean	_
23-41	4252-4255	age	_
23-42	4256-4257	:	_
23-43	4258-4260	26	_
23-44	4261-4262	,	_
23-45	4263-4268	range	_
23-46	4269-4270	:	_
23-47	4271-4276	22–39	_
23-48	4277-4278	)	_
23-49	4279-4280	.	_

Text=There is no standard way to perform power analyses for non-parametric analyses, such as those that are employed in this work.
24-1	4281-4286	There	_
24-2	4287-4289	is	_
24-3	4290-4292	no	_
24-4	4293-4301	standard	_
24-5	4302-4305	way	_
24-6	4306-4308	to	_
24-7	4309-4316	perform	_
24-8	4317-4322	power	_
24-9	4323-4331	analyses	_
24-10	4332-4335	for	_
24-11	4336-4350	non-parametric	_
24-12	4351-4359	analyses	_
24-13	4360-4361	,	_
24-14	4362-4366	such	_
24-15	4367-4369	as	_
24-16	4370-4375	those	_
24-17	4376-4380	that	_
24-18	4381-4384	are	_
24-19	4385-4393	employed	_
24-20	4394-4396	in	_
24-21	4397-4401	this	_
24-22	4402-4406	work	_
24-23	4407-4408	.	_

Text=The estimated power of a corresponding parametric t-test with the same number of participants as in the selected sample is 0.77 for ToM NCI, and 0.99 for ES NCI.
25-1	4409-4412	The	_
25-2	4413-4422	estimated	_
25-3	4423-4428	power	_
25-4	4429-4431	of	_
25-5	4432-4433	a	_
25-6	4434-4447	corresponding	_
25-7	4448-4458	parametric	_
25-8	4459-4465	t-test	_
25-9	4466-4470	with	_
25-10	4471-4474	the	_
25-11	4475-4479	same	_
25-12	4480-4486	number	_
25-13	4487-4489	of	_
25-14	4490-4502	participants	_
25-15	4503-4505	as	_
25-16	4506-4508	in	_
25-17	4509-4512	the	_
25-18	4513-4521	selected	_
25-19	4522-4528	sample	_
25-20	4529-4531	is	_
25-21	4532-4536	0.77	_
25-22	4537-4540	for	_
25-23	4541-4544	ToM	_
25-24	4545-4548	NCI	_
25-25	4549-4550	,	_
25-26	4551-4554	and	_
25-27	4555-4559	0.99	_
25-28	4560-4563	for	_
25-29	4564-4566	ES	_
25-30	4567-4570	NCI	_
25-31	4571-4572	.	_

Text=These values were estimated based on data from the time window of the highest mean difference between these the group NCIs (following ref.
26-1	4573-4578	These	_
26-2	4579-4585	values	_
26-3	4586-4590	were	_
26-4	4591-4600	estimated	_
26-5	4601-4606	based	_
26-6	4607-4609	on	_
26-7	4610-4614	data	_
26-8	4615-4619	from	_
26-9	4620-4623	the	_
26-10	4624-4628	time	_
26-11	4629-4635	window	_
26-12	4636-4638	of	_
26-13	4639-4642	the	_
26-14	4643-4650	highest	_
26-15	4651-4655	mean	_
26-16	4656-4666	difference	_
26-17	4667-4674	between	_
26-18	4675-4680	these	_
26-19	4681-4684	the	_
26-20	4685-4690	group	_
26-21	4691-4695	NCIs	_
26-22	4696-4697	(	_
26-23	4698-4707	following	_
26-24	4708-4711	ref	_
26-25	4712-4713	.	_

Text=).
27-1	4714-4715	)	_
27-2	4716-4717	.	_

Text=The study was approved by the Institutional Review Boards in each of the mental health centers.
28-1	4718-4721	The	_
28-2	4722-4727	study	_
28-3	4728-4731	was	_
28-4	4732-4740	approved	_
28-5	4741-4743	by	_
28-6	4744-4747	the	_
28-7	4748-4761	Institutional	_
28-8	4762-4768	Review	_
28-9	4769-4775	Boards	_
28-10	4776-4778	in	_
28-11	4779-4783	each	_
28-12	4784-4786	of	_
28-13	4787-4790	the	_
28-14	4791-4797	mental	_
28-15	4798-4804	health	_
28-16	4805-4812	centers	_
28-17	4813-4814	.	_

Text=All participants gave written informed consent after receiving a full explanation of the study protocol.
29-1	4815-4818	All	_
29-2	4819-4831	participants	_
29-3	4832-4836	gave	_
29-4	4837-4844	written	_
29-5	4845-4853	informed	_
29-6	4854-4861	consent	_
29-7	4862-4867	after	_
29-8	4868-4877	receiving	_
29-9	4878-4879	a	_
29-10	4880-4884	full	_
29-11	4885-4896	explanation	_
29-12	4897-4899	of	_
29-13	4900-4903	the	_
29-14	4904-4909	study	_
29-15	4910-4918	protocol	_
29-16	4919-4920	.	_

Text=Task The cinematic stimulus was selected due to its high ecological validity and the efficiency of movies as inducers of emotion.
30-1	4921-4925	Task	_
30-2	4926-4929	The	_
30-3	4930-4939	cinematic	_
30-4	4940-4948	stimulus	_
30-5	4949-4952	was	_
30-6	4953-4961	selected	_
30-7	4962-4965	due	_
30-8	4966-4968	to	_
30-9	4969-4972	its	_
30-10	4973-4977	high	_
30-11	4978-4988	ecological	_
30-12	4989-4997	validity	_
30-13	4998-5001	and	_
30-14	5002-5005	the	_
30-15	5006-5016	efficiency	_
30-16	5017-5019	of	_
30-17	5020-5026	movies	_
30-18	5027-5029	as	_
30-19	5030-5038	inducers	_
30-20	5039-5041	of	_
30-21	5042-5049	emotion	_
30-22	5050-5051	.	_

Text=Participants passively watched a clip from the movie “ The Ring 2 ” (8:15 min) with Hebrew subtitles while in the scanner.
31-1	5052-5064	Participants	_
31-2	5065-5074	passively	_
31-3	5075-5082	watched	_
31-4	5083-5084	a	_
31-5	5085-5089	clip	_
31-6	5090-5094	from	_
31-7	5095-5098	the	_
31-8	5099-5104	movie	_
31-9	5105-5106	“	_
31-10	5107-5110	The	_
31-11	5111-5115	Ring	_
31-12	5116-5117	2	_
31-13	5118-5119	”	_
31-14	5120-5121	(	_
31-15	5122-5126	8:15	_
31-16	5127-5130	min	_
31-17	5131-5132	)	_
31-18	5133-5137	with	_
31-19	5138-5144	Hebrew	_
31-20	5145-5154	subtitles	_
31-21	5155-5160	while	_
31-22	5161-5163	in	_
31-23	5164-5167	the	_
31-24	5168-5175	scanner	_
31-25	5176-5177	.	_

Text=The clip included two dramatic emotional peaks: a mother looking for her son while experiencing a frightful delirium in the amusement park restroom (~2 min), and a deer attacking the mother and son (2 min).
32-1	5178-5181	The	_
32-2	5182-5186	clip	_
32-3	5187-5195	included	_
32-4	5196-5199	two	_
32-5	5200-5208	dramatic	_
32-6	5209-5218	emotional	_
32-7	5219-5224	peaks	_
32-8	5225-5226	:	_
32-9	5227-5228	a	_
32-10	5229-5235	mother	_
32-11	5236-5243	looking	_
32-12	5244-5247	for	_
32-13	5248-5251	her	_
32-14	5252-5255	son	_
32-15	5256-5261	while	_
32-16	5262-5274	experiencing	_
32-17	5275-5276	a	_
32-18	5277-5286	frightful	_
32-19	5287-5295	delirium	_
32-20	5296-5298	in	_
32-21	5299-5302	the	_
32-22	5303-5312	amusement	_
32-23	5313-5317	park	_
32-24	5318-5326	restroom	_
32-25	5327-5328	(	_
32-26	5329-5331	~2	_
32-27	5332-5335	min	_
32-28	5336-5337	)	_
32-29	5338-5339	,	_
32-30	5340-5343	and	_
32-31	5344-5345	a	_
32-32	5346-5350	deer	_
32-33	5351-5360	attacking	_
32-34	5361-5364	the	_
32-35	5365-5371	mother	_
32-36	5372-5375	and	_
32-37	5376-5379	son	_
32-38	5380-5381	(	_
32-39	5382-5383	2	_
32-40	5384-5387	min	_
32-41	5388-5389	)	_
32-42	5390-5391	.	_

Text=Participants passively viewed a blank screen for 1 min before and after the film was presented.
33-1	5392-5404	Participants	_
33-2	5405-5414	passively	_
33-3	5415-5421	viewed	_
33-4	5422-5423	a	_
33-5	5424-5429	blank	_
33-6	5430-5436	screen	_
33-7	5437-5440	for	_
33-8	5441-5442	1	_
33-9	5443-5446	min	_
33-10	5447-5453	before	_
33-11	5454-5457	and	_
33-12	5458-5463	after	_
33-13	5464-5467	the	_
33-14	5468-5472	film	_
33-15	5473-5476	was	_
33-16	5477-5486	presented	_
33-17	5487-5488	.	_

Text=Continuous fear rating Due to technical issues valid post-scanning continuous fear rating were obtained from 24 schizophrenia patients (9 females, mean age: 27.2, range: 19–40) and only 10 of the healthy controls (1 female, mean age: 26, range: 22–39).
34-1	5489-5499	Continuous	_
34-2	5500-5504	fear	_
34-3	5505-5511	rating	_
34-4	5512-5515	Due	_
34-5	5516-5518	to	_
34-6	5519-5528	technical	_
34-7	5529-5535	issues	_
34-8	5536-5541	valid	_
34-9	5542-5555	post-scanning	_
34-10	5556-5566	continuous	_
34-11	5567-5571	fear	_
34-12	5572-5578	rating	_
34-13	5579-5583	were	_
34-14	5584-5592	obtained	_
34-15	5593-5597	from	_
34-16	5598-5600	24	_
34-17	5601-5614	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
34-18	5615-5623	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
34-19	5624-5625	(	_
34-20	5626-5627	9	_
34-21	5628-5635	females	_
34-22	5636-5637	,	_
34-23	5638-5642	mean	_
34-24	5643-5646	age	_
34-25	5647-5648	:	_
34-26	5649-5653	27.2	_
34-27	5654-5655	,	_
34-28	5656-5661	range	_
34-29	5662-5663	:	_
34-30	5664-5669	19–40	_
34-31	5670-5671	)	_
34-32	5672-5675	and	_
34-33	5676-5680	only	_
34-34	5681-5683	10	_
34-35	5684-5686	of	_
34-36	5687-5690	the	_
34-37	5691-5698	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
34-38	5699-5707	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
34-39	5708-5709	(	_
34-40	5710-5711	1	_
34-41	5712-5718	female	_
34-42	5719-5720	,	_
34-43	5721-5725	mean	_
34-44	5726-5729	age	_
34-45	5730-5731	:	_
34-46	5732-5734	26	_
34-47	5735-5736	,	_
34-48	5737-5742	range	_
34-49	5743-5744	:	_
34-50	5745-5750	22–39	_
34-51	5751-5752	)	_
34-52	5753-5754	.	_

Text=To improve the estimation of the rating pattern of the healthy population, we included data from 77 additional healthy volunteers.
35-1	5755-5757	To	_
35-2	5758-5765	improve	_
35-3	5766-5769	the	_
35-4	5770-5780	estimation	_
35-5	5781-5783	of	_
35-6	5784-5787	the	_
35-7	5788-5794	rating	_
35-8	5795-5802	pattern	_
35-9	5803-5805	of	_
35-10	5806-5809	the	_
35-11	5810-5817	healthy	_
35-12	5818-5828	population	_
35-13	5829-5830	,	_
35-14	5831-5833	we	_
35-15	5834-5842	included	_
35-16	5843-5847	data	_
35-17	5848-5852	from	_
35-18	5853-5855	77	_
35-19	5856-5866	additional	_
35-20	5867-5874	healthy	_
35-21	5875-5885	volunteers	_
35-22	5886-5887	.	_

Text=Thus, in total, the group included 87 healthy controls (33 females, mean age: 25.6, range: 20–40).
36-1	5888-5892	Thus	_
36-2	5893-5894	,	_
36-3	5895-5897	in	_
36-4	5898-5903	total	_
36-5	5904-5905	,	_
36-6	5906-5909	the	_
36-7	5910-5915	group	_
36-8	5916-5924	included	_
36-9	5925-5927	87	_
36-10	5928-5935	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
36-11	5936-5944	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
36-12	5945-5946	(	_
36-13	5947-5949	33	_
36-14	5950-5957	females	_
36-15	5958-5959	,	_
36-16	5960-5964	mean	_
36-17	5965-5968	age	_
36-18	5969-5970	:	_
36-19	5971-5975	25.6	_
36-20	5976-5977	,	_
36-21	5978-5983	range	_
36-22	5984-5985	:	_
36-23	5986-5991	20–40	_
36-24	5992-5993	)	_
36-25	5994-5995	.	_

Text=It should be noted that the median ratings of the smaller and later expanded healthy control groups were highly correlated (Spearman R = 0.98, p <5 × 10−102).
37-1	5996-5998	It	_
37-2	5999-6005	should	_
37-3	6006-6008	be	_
37-4	6009-6014	noted	_
37-5	6015-6019	that	_
37-6	6020-6023	the	_
37-7	6024-6030	median	_
37-8	6031-6038	ratings	_
37-9	6039-6041	of	_
37-10	6042-6045	the	_
37-11	6046-6053	smaller	_
37-12	6054-6057	and	_
37-13	6058-6063	later	_
37-14	6064-6072	expanded	_
37-15	6073-6080	healthy	_
37-16	6081-6088	control	_
37-17	6089-6095	groups	_
37-18	6096-6100	were	_
37-19	6101-6107	highly	_
37-20	6108-6118	correlated	_
37-21	6119-6120	(	_
37-22	6121-6129	Spearman	_
37-23	6130-6131	R	_
37-24	6132-6133	=	_
37-25	6134-6138	0.98	_
37-26	6139-6140	,	_
37-27	6141-6142	p	_
37-28	6143-6144	<	_
37-29	6145-6146	5	_
37-30	6147-6148	×	_
37-31	6149-6155	10−102	_
37-32	6156-6157	)	_
37-33	6158-6159	.	_

Text=In the post-scan session, the participants watched the movie clip for a second time while continuously and retrospectively rating the fear intensity they recalled feeling during the first viewing in the scanner.
38-1	6160-6162	In	_
38-2	6163-6166	the	_
38-3	6167-6176	post-scan	_
38-4	6177-6184	session	_
38-5	6185-6186	,	_
38-6	6187-6190	the	_
38-7	6191-6203	participants	_
38-8	6204-6211	watched	_
38-9	6212-6215	the	_
38-10	6216-6221	movie	_
38-11	6222-6226	clip	_
38-12	6227-6230	for	_
38-13	6231-6232	a	_
38-14	6233-6239	second	_
38-15	6240-6244	time	_
38-16	6245-6250	while	_
38-17	6251-6263	continuously	_
38-18	6264-6267	and	_
38-19	6268-6283	retrospectively	_
38-20	6284-6290	rating	_
38-21	6291-6294	the	_
38-22	6295-6299	fear	_
38-23	6300-6309	intensity	_
38-24	6310-6314	they	_
38-25	6315-6323	recalled	_
38-26	6324-6331	feeling	_
38-27	6332-6338	during	_
38-28	6339-6342	the	_
38-29	6343-6348	first	_
38-30	6349-6356	viewing	_
38-31	6357-6359	in	_
38-32	6360-6363	the	_
38-33	6364-6371	scanner	_
38-34	6372-6373	.	_

Text=The rating was performed retrospectively to avoid the confounding effect of rating while being in the scanner for the first time.
39-1	6374-6377	The	_
39-2	6378-6384	rating	_
39-3	6385-6388	was	_
39-4	6389-6398	performed	_
39-5	6399-6414	retrospectively	_
39-6	6415-6417	to	_
39-7	6418-6423	avoid	_
39-8	6424-6427	the	_
39-9	6428-6439	confounding	_
39-10	6440-6446	effect	_
39-11	6447-6449	of	_
39-12	6450-6456	rating	_
39-13	6457-6462	while	_
39-14	6463-6468	being	_
39-15	6469-6471	in	_
39-16	6472-6475	the	_
39-17	6476-6483	scanner	_
39-18	6484-6487	for	_
39-19	6488-6491	the	_
39-20	6492-6497	first	_
39-21	6498-6502	time	_
39-22	6503-6504	.	_

Text=Fear was the targeted emotion because it can be considered an “ empathic emotion ” inducer, since a threat is being posed to a cinematic character rather than to the subject themselves.
40-1	6505-6509	Fear	_
40-2	6510-6513	was	_
40-3	6514-6517	the	_
40-4	6518-6526	targeted	_
40-5	6527-6534	emotion	_
40-6	6535-6542	because	_
40-7	6543-6545	it	_
40-8	6546-6549	can	_
40-9	6550-6552	be	_
40-10	6553-6563	considered	_
40-11	6564-6566	an	_
40-12	6567-6568	“	_
40-13	6569-6577	empathic	_
40-14	6578-6585	emotion	_
40-15	6586-6587	”	_
40-16	6588-6595	inducer	_
40-17	6596-6597	,	_
40-18	6598-6603	since	_
40-19	6604-6605	a	_
40-20	6606-6612	threat	_
40-21	6613-6615	is	_
40-22	6616-6621	being	_
40-23	6622-6627	posed	_
40-24	6628-6630	to	_
40-25	6631-6632	a	_
40-26	6633-6642	cinematic	_
40-27	6643-6652	character	_
40-28	6653-6659	rather	_
40-29	6660-6664	than	_
40-30	6665-6667	to	_
40-31	6668-6671	the	_
40-32	6672-6679	subject	_
40-33	6680-6690	themselves	_
40-34	6691-6692	.	_

Text=The rating was sampled at 10 Hz using in-house software.
41-1	6693-6696	The	_
41-2	6697-6703	rating	_
41-3	6704-6707	was	_
41-4	6708-6715	sampled	_
41-5	6716-6718	at	_
41-6	6719-6721	10	_
41-7	6722-6724	Hz	_
41-8	6725-6730	using	_
41-9	6731-6739	in-house	_
41-10	6740-6748	software	_
41-11	6749-6750	.	_

Text=The participants used a vertical scale indicating 7 levels of fear—from neutral to very deep (each containing 3° of shift; 21° in total).
42-1	6751-6754	The	_
42-2	6755-6767	participants	_
42-3	6768-6772	used	_
42-4	6773-6774	a	_
42-5	6775-6783	vertical	_
42-6	6784-6789	scale	_
42-7	6790-6800	indicating	_
42-8	6801-6802	7	_
42-9	6803-6809	levels	_
42-10	6810-6812	of	_
42-11	6813-6822	fear—from	_
42-12	6823-6830	neutral	_
42-13	6831-6833	to	_
42-14	6834-6838	very	_
42-15	6839-6843	deep	_
42-16	6844-6845	(	_
42-17	6846-6850	each	_
42-18	6851-6861	containing	_
42-19	6862-6864	3°	_
42-20	6865-6867	of	_
42-21	6868-6873	shift	_
42-22	6874-6875	;	_
42-23	6876-6879	21°	_
42-24	6880-6882	in	_
42-25	6883-6888	total	_
42-26	6889-6890	)	_
42-27	6891-6892	.	_

Text=fMRI data acquisition and preprocessing fMRI scanning was performed using a GE 3 T Signa Excite echo speed scanner with an eight-channel head coil located at the Tel-Aviv Sourasky Medical Center.
43-1	6893-6897	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
43-2	6898-6902	data	_
43-3	6903-6914	acquisition	_
43-4	6915-6918	and	_
43-5	6919-6932	preprocessing	_
43-6	6933-6937	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
43-7	6938-6946	scanning	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
43-8	6947-6950	was	_
43-9	6951-6960	performed	_
43-10	6961-6966	using	_
43-11	6967-6968	a	_
43-12	6969-6971	GE	_
43-13	6972-6973	3	http://maven.renci.org/NeuroBridge/neurobridge#2Level
43-14	6974-6975	T	http://maven.renci.org/NeuroBridge/neurobridge#2Level
43-15	6976-6981	Signa	http://maven.renci.org/NeuroBridge/neurobridge#2Level
43-16	6982-6988	Excite	http://maven.renci.org/NeuroBridge/neurobridge#2Level
43-17	6989-6993	echo	http://maven.renci.org/NeuroBridge/neurobridge#2Level
43-18	6994-6999	speed	http://maven.renci.org/NeuroBridge/neurobridge#2Level
43-19	7000-7007	scanner	http://maven.renci.org/NeuroBridge/neurobridge#2Level
43-20	7008-7012	with	_
43-21	7013-7015	an	_
43-22	7016-7029	eight-channel	_
43-23	7030-7034	head	_
43-24	7035-7039	coil	_
43-25	7040-7047	located	_
43-26	7048-7050	at	_
43-27	7051-7054	the	_
43-28	7055-7063	Tel-Aviv	_
43-29	7064-7072	Sourasky	_
43-30	7073-7080	Medical	_
43-31	7081-7087	Center	_
43-32	7088-7089	.	_

Text=Structural scans included a T1-weighted 3D axial spoiled gradient echo (SPGR) pulse sequence (TR/TE = 8.94/3.48 ms, slice thickness = 1 mm, flip angle = 13°, pixel size = 1 mm, FOV = 256 × 256 mm).
44-1	7090-7100	Structural	_
44-2	7101-7106	scans	_
44-3	7107-7115	included	_
44-4	7116-7117	a	_
44-5	7118-7129	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-6	7130-7132	3D	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-7	7133-7138	axial	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-8	7139-7146	spoiled	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-9	7147-7155	gradient	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-10	7156-7160	echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-11	7161-7162	(	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-12	7163-7167	SPGR	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-13	7168-7169	)	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
44-14	7170-7175	pulse	_
44-15	7176-7184	sequence	_
44-16	7185-7186	(	_
44-17	7187-7192	TR/TE	_
44-18	7193-7194	=	_
44-19	7195-7204	8.94/3.48	_
44-20	7205-7207	ms	_
44-21	7208-7209	,	_
44-22	7210-7215	slice	_
44-23	7216-7225	thickness	_
44-24	7226-7227	=	_
44-25	7228-7229	1	_
44-26	7230-7232	mm	_
44-27	7233-7234	,	_
44-28	7235-7239	flip	_
44-29	7240-7245	angle	_
44-30	7246-7247	=	_
44-31	7248-7251	13°	_
44-32	7252-7253	,	_
44-33	7254-7259	pixel	_
44-34	7260-7264	size	_
44-35	7265-7266	=	_
44-36	7267-7268	1	_
44-37	7269-7271	mm	_
44-38	7272-7273	,	_
44-39	7274-7277	FOV	_
44-40	7278-7279	=	_
44-41	7280-7283	256	_
44-42	7284-7285	×	_
44-43	7286-7289	256	_
44-44	7290-7292	mm	_
44-45	7293-7294	)	_
44-46	7295-7296	.	_

Text=Functional whole-brain scans were performed in interleaved order with a T2 * -weighted gradient echo planar imaging pulse sequence (time repetition [TR] /TE = 3000/35 ms, flip angle = 90°, pixel size = 1.56 mm, FOV = 200 × 200 mm, slice thickness = 3 mm, 39 slices per volume).
45-1	7297-7307	Functional	_
45-2	7308-7319	whole-brain	_
45-3	7320-7325	scans	_
45-4	7326-7330	were	_
45-5	7331-7340	performed	_
45-6	7341-7343	in	_
45-7	7344-7355	interleaved	_
45-8	7356-7361	order	_
45-9	7362-7366	with	_
45-10	7367-7368	a	_
45-11	7369-7371	T2	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-12	7372-7373	*	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-13	7374-7383	-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-14	7384-7392	gradient	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-15	7393-7397	echo	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-16	7398-7404	planar	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-17	7405-7412	imaging	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-18	7413-7418	pulse	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
45-19	7419-7427	sequence	_
45-20	7428-7429	(	_
45-21	7430-7434	time	_
45-22	7435-7445	repetition	_
45-23	7446-7447	[	_
45-24	7448-7450	TR	_
45-25	7451-7452	]	_
45-26	7453-7456	/TE	_
45-27	7457-7458	=	_
45-28	7459-7466	3000/35	_
45-29	7467-7469	ms	_
45-30	7470-7471	,	_
45-31	7472-7476	flip	_
45-32	7477-7482	angle	_
45-33	7483-7484	=	_
45-34	7485-7488	90°	_
45-35	7489-7490	,	_
45-36	7491-7496	pixel	_
45-37	7497-7501	size	_
45-38	7502-7503	=	_
45-39	7504-7508	1.56	_
45-40	7509-7511	mm	_
45-41	7512-7513	,	_
45-42	7514-7517	FOV	_
45-43	7518-7519	=	_
45-44	7520-7523	200	_
45-45	7524-7525	×	_
45-46	7526-7529	200	_
45-47	7530-7532	mm	_
45-48	7533-7534	,	_
45-49	7535-7540	slice	_
45-50	7541-7550	thickness	_
45-51	7551-7552	=	_
45-52	7553-7554	3	_
45-53	7555-7557	mm	_
45-54	7558-7559	,	_
45-55	7560-7562	39	_
45-56	7563-7569	slices	_
45-57	7570-7573	per	_
45-58	7574-7580	volume	_
45-59	7581-7582	)	_
45-60	7583-7584	.	_

Text=Active noise canceling headphones (Optoacoustics) were used.
46-1	7585-7591	Active	_
46-2	7592-7597	noise	_
46-3	7598-7607	canceling	_
46-4	7608-7618	headphones	_
46-5	7619-7620	(	_
46-6	7621-7634	Optoacoustics	_
46-7	7635-7636	)	_
46-8	7637-7641	were	_
46-9	7642-7646	used	_
46-10	7647-7648	.	_

Text=Brain Voyager QX 2.4 was used for preprocessing and co-registration of the standardized anatomical and functional data.
47-1	7649-7654	Brain	_
47-2	7655-7662	Voyager	_
47-3	7663-7665	QX	_
47-4	7666-7669	2.4	_
47-5	7670-7673	was	_
47-6	7674-7678	used	_
47-7	7679-7682	for	_
47-8	7683-7696	preprocessing	_
47-9	7697-7700	and	_
47-10	7701-7716	co-registration	_
47-11	7717-7719	of	_
47-12	7720-7723	the	_
47-13	7724-7736	standardized	_
47-14	7737-7747	anatomical	_
47-15	7748-7751	and	_
47-16	7752-7762	functional	_
47-17	7763-7767	data	_
47-18	7768-7769	.	_

Text=Head motions were detected and corrected using trilinear and sinc interpolations respectively, applying rigid body transformations with three translation and three rotation parameters.
48-1	7770-7774	Head	_
48-2	7775-7782	motions	_
48-3	7783-7787	were	_
48-4	7788-7796	detected	_
48-5	7797-7800	and	_
48-6	7801-7810	corrected	_
48-7	7811-7816	using	_
48-8	7817-7826	trilinear	_
48-9	7827-7830	and	_
48-10	7831-7835	sinc	_
48-11	7836-7850	interpolations	_
48-12	7851-7863	respectively	_
48-13	7864-7865	,	_
48-14	7866-7874	applying	_
48-15	7875-7880	rigid	_
48-16	7881-7885	body	_
48-17	7886-7901	transformations	_
48-18	7902-7906	with	_
48-19	7907-7912	three	_
48-20	7913-7924	translation	_
48-21	7925-7928	and	_
48-22	7929-7934	three	_
48-23	7935-7943	rotation	_
48-24	7944-7954	parameters	_
48-25	7955-7956	.	_

Text=The data were high-pass filtered at 0.008 Hz and spatial smoothed with a 6 mm FWHM kernel.
49-1	7957-7960	The	_
49-2	7961-7965	data	_
49-3	7966-7970	were	_
49-4	7971-7980	high-pass	_
49-5	7981-7989	filtered	_
49-6	7990-7992	at	_
49-7	7993-7998	0.008	_
49-8	7999-8001	Hz	_
49-9	8002-8005	and	_
49-10	8006-8013	spatial	_
49-11	8014-8022	smoothed	_
49-12	8023-8027	with	_
49-13	8028-8029	a	_
49-14	8030-8031	6	_
49-15	8032-8034	mm	_
49-16	8035-8039	FWHM	_
49-17	8040-8046	kernel	_
49-18	8047-8048	.	_

Text=To avoid the confounding effects of fluctuations in the whole-brain BOLD signal, for each TR, each voxel was scaled by the global mean at that time point.
50-1	8049-8051	To	_
50-2	8052-8057	avoid	_
50-3	8058-8061	the	_
50-4	8062-8073	confounding	_
50-5	8074-8081	effects	_
50-6	8082-8084	of	_
50-7	8085-8097	fluctuations	_
50-8	8098-8100	in	_
50-9	8101-8104	the	_
50-10	8105-8116	whole-brain	_
50-11	8117-8121	BOLD	_
50-12	8122-8128	signal	_
50-13	8129-8130	,	_
50-14	8131-8134	for	_
50-15	8135-8139	each	_
50-16	8140-8142	TR	_
50-17	8143-8144	,	_
50-18	8145-8149	each	_
50-19	8150-8155	voxel	_
50-20	8156-8159	was	_
50-21	8160-8166	scaled	_
50-22	8167-8169	by	_
50-23	8170-8173	the	_
50-24	8174-8180	global	_
50-25	8181-8185	mean	_
50-26	8186-8188	at	_
50-27	8189-8193	that	_
50-28	8194-8198	time	_
50-29	8199-8204	point	_
50-30	8205-8206	.	_

Text=Due to head movements (deviations higher than 1.5°/1.5 mm relative to the reference) three patients and one healthy control were excluded from the study.
51-1	8207-8210	Due	_
51-2	8211-8213	to	_
51-3	8214-8218	head	_
51-4	8219-8228	movements	_
51-5	8229-8230	(	_
51-6	8231-8241	deviations	_
51-7	8242-8248	higher	_
51-8	8249-8253	than	_
51-9	8254-8262	1.5°/1.5	_
51-10	8263-8265	mm	_
51-11	8266-8274	relative	_
51-12	8275-8277	to	_
51-13	8278-8281	the	_
51-14	8282-8291	reference	_
51-15	8292-8293	)	_
51-16	8294-8299	three	_
51-17	8300-8308	patients	_
51-18	8309-8312	and	_
51-19	8313-8316	one	_
51-20	8317-8324	healthy	_
51-21	8325-8332	control	_
51-22	8333-8337	were	_
51-23	8338-8346	excluded	_
51-24	8347-8351	from	_
51-25	8352-8355	the	_
51-26	8356-8361	study	_
51-27	8362-8363	.	_

Text=Finally, we trimmed the functional data to improve the specificity of our analysis.
52-1	8364-8371	Finally	_
52-2	8372-8373	,	_
52-3	8374-8376	we	_
52-4	8377-8384	trimmed	_
52-5	8385-8388	the	_
52-6	8389-8399	functional	_
52-7	8400-8404	data	_
52-8	8405-8407	to	_
52-9	8408-8415	improve	_
52-10	8416-8419	the	_
52-11	8420-8431	specificity	_
52-12	8432-8434	of	_
52-13	8435-8438	our	_
52-14	8439-8447	analysis	_
52-15	8448-8449	.	_

Text=The onset of the cinematic stimulus after a minute of rest may evoke emotional response regardless of the content of the film.
53-1	8450-8453	The	_
53-2	8454-8459	onset	_
53-3	8460-8462	of	_
53-4	8463-8466	the	_
53-5	8467-8476	cinematic	_
53-6	8477-8485	stimulus	_
53-7	8486-8491	after	_
53-8	8492-8493	a	_
53-9	8494-8500	minute	_
53-10	8501-8503	of	_
53-11	8504-8508	rest	_
53-12	8509-8512	may	_
53-13	8513-8518	evoke	_
53-14	8519-8528	emotional	_
53-15	8529-8537	response	_
53-16	8538-8548	regardless	_
53-17	8549-8551	of	_
53-18	8552-8555	the	_
53-19	8556-8563	content	_
53-20	8564-8566	of	_
53-21	8567-8570	the	_
53-22	8571-8575	film	_
53-23	8576-8577	.	_

Text=Since we were not interested in this psychological effect, we removed a segment of five TRs from the functional data that were collected during the film viewing.
54-1	8578-8583	Since	_
54-2	8584-8586	we	_
54-3	8587-8591	were	_
54-4	8592-8595	not	_
54-5	8596-8606	interested	_
54-6	8607-8609	in	_
54-7	8610-8614	this	_
54-8	8615-8628	psychological	_
54-9	8629-8635	effect	_
54-10	8636-8637	,	_
54-11	8638-8640	we	_
54-12	8641-8648	removed	_
54-13	8649-8650	a	_
54-14	8651-8658	segment	_
54-15	8659-8661	of	_
54-16	8662-8666	five	_
54-17	8667-8670	TRs	_
54-18	8671-8675	from	_
54-19	8676-8679	the	_
54-20	8680-8690	functional	_
54-21	8691-8695	data	_
54-22	8696-8700	that	_
54-23	8701-8705	were	_
54-24	8706-8715	collected	_
54-25	8716-8722	during	_
54-26	8723-8726	the	_
54-27	8727-8731	film	_
54-28	8732-8739	viewing	_
54-29	8740-8741	.	_

Text=The size of this segment was set to five TRs to discard the hemodynamic response to the film onset, as this response typically lasts 12–16 s. A segment including the five first time points was removed from the rating as well so that these signals could be comparable.
55-1	8742-8745	The	_
55-2	8746-8750	size	_
55-3	8751-8753	of	_
55-4	8754-8758	this	_
55-5	8759-8766	segment	_
55-6	8767-8770	was	_
55-7	8771-8774	set	_
55-8	8775-8777	to	_
55-9	8778-8782	five	_
55-10	8783-8786	TRs	_
55-11	8787-8789	to	_
55-12	8790-8797	discard	_
55-13	8798-8801	the	_
55-14	8802-8813	hemodynamic	_
55-15	8814-8822	response	_
55-16	8823-8825	to	_
55-17	8826-8829	the	_
55-18	8830-8834	film	_
55-19	8835-8840	onset	_
55-20	8841-8842	,	_
55-21	8843-8845	as	_
55-22	8846-8850	this	_
55-23	8851-8859	response	_
55-24	8860-8869	typically	_
55-25	8870-8875	lasts	_
55-26	8876-8881	12–16	_
55-27	8882-8884	s.	_
55-28	8885-8886	A	_
55-29	8887-8894	segment	_
55-30	8895-8904	including	_
55-31	8905-8908	the	_
55-32	8909-8913	five	_
55-33	8914-8919	first	_
55-34	8920-8924	time	_
55-35	8925-8931	points	_
55-36	8932-8935	was	_
55-37	8936-8943	removed	_
55-38	8944-8948	from	_
55-39	8949-8952	the	_
55-40	8953-8959	rating	_
55-41	8960-8962	as	_
55-42	8963-8967	well	_
55-43	8968-8970	so	_
55-44	8971-8975	that	_
55-45	8976-8981	these	_
55-46	8982-8989	signals	_
55-47	8990-8995	could	_
55-48	8996-8998	be	_
55-49	8999-9009	comparable	_
55-50	9010-9011	.	_

Text=Defining networks of interest The anatomical definition of social cognition-related networks relied on two relevant meta-analyses of ES and ToM neuroimaging studies (Fig.
56-1	9012-9020	Defining	_
56-2	9021-9029	networks	_
56-3	9030-9032	of	_
56-4	9033-9041	interest	_
56-5	9042-9045	The	_
56-6	9046-9056	anatomical	_
56-7	9057-9067	definition	_
56-8	9068-9070	of	_
56-9	9071-9077	social	_
56-10	9078-9095	cognition-related	_
56-11	9096-9104	networks	_
56-12	9105-9111	relied	_
56-13	9112-9114	on	_
56-14	9115-9118	two	_
56-15	9119-9127	relevant	_
56-16	9128-9141	meta-analyses	_
56-17	9142-9144	of	_
56-18	9145-9147	ES	_
56-19	9148-9151	and	_
56-20	9152-9155	ToM	_
56-21	9156-9168	neuroimaging	_
56-22	9169-9176	studies	_
56-23	9177-9178	(	_
56-24	9179-9182	Fig	_
56-25	9183-9184	.	_

Text=1a, Table S2).
57-1	9185-9187	1a	_
57-2	9188-9189	,	_
57-3	9190-9195	Table	_
57-4	9196-9198	S2	_
57-5	9199-9200	)	_
57-6	9201-9202	.	_

Text=Both networks were used in a previous analysis of network cohesion applied to data collected during the viewing of two additional cinematic contents used in our lab.
58-1	9203-9207	Both	_
58-2	9208-9216	networks	_
58-3	9217-9221	were	_
58-4	9222-9226	used	_
58-5	9227-9229	in	_
58-6	9230-9231	a	_
58-7	9232-9240	previous	_
58-8	9241-9249	analysis	_
58-9	9250-9252	of	_
58-10	9253-9260	network	_
58-11	9261-9269	cohesion	_
58-12	9270-9277	applied	_
58-13	9278-9280	to	_
58-14	9281-9285	data	_
58-15	9286-9295	collected	_
58-16	9296-9302	during	_
58-17	9303-9306	the	_
58-18	9307-9314	viewing	_
58-19	9315-9317	of	_
58-20	9318-9321	two	_
58-21	9322-9332	additional	_
58-22	9333-9342	cinematic	_
58-23	9343-9351	contents	_
58-24	9352-9356	used	_
58-25	9357-9359	in	_
58-26	9360-9363	our	_
58-27	9364-9367	lab	_
58-28	9368-9369	.	_

Text=The statistical maps were kindly provided by the authors of refs.
59-1	9370-9373	The	_
59-2	9374-9385	statistical	_
59-3	9386-9390	maps	_
59-4	9391-9395	were	_
59-5	9396-9402	kindly	_
59-6	9403-9411	provided	_
59-7	9412-9414	by	_
59-8	9415-9418	the	_
59-9	9419-9426	authors	_
59-10	9427-9429	of	_
59-11	9430-9434	refs	_
59-12	9435-9436	.	_

Text=and, respectively.
60-1	9437-9440	and	_
60-2	9441-9442	,	_
60-3	9443-9455	respectively	_
60-4	9456-9457	.	_

Text=The defined ES network was based on a meta-analysis of studies on vicarious pain experiences and included regions that were activated both during first-hand experiences of pain and while observing the pain of another.
61-1	9458-9461	The	_
61-2	9462-9469	defined	_
61-3	9470-9472	ES	_
61-4	9473-9480	network	_
61-5	9481-9484	was	_
61-6	9485-9490	based	_
61-7	9491-9493	on	_
61-8	9494-9495	a	_
61-9	9496-9509	meta-analysis	_
61-10	9510-9512	of	_
61-11	9513-9520	studies	_
61-12	9521-9523	on	_
61-13	9524-9533	vicarious	_
61-14	9534-9538	pain	_
61-15	9539-9550	experiences	_
61-16	9551-9554	and	_
61-17	9555-9563	included	_
61-18	9564-9571	regions	_
61-19	9572-9576	that	_
61-20	9577-9581	were	_
61-21	9582-9591	activated	_
61-22	9592-9596	both	_
61-23	9597-9603	during	_
61-24	9604-9614	first-hand	_
61-25	9615-9626	experiences	_
61-26	9627-9629	of	_
61-27	9630-9634	pain	_
61-28	9635-9638	and	_
61-29	9639-9644	while	_
61-30	9645-9654	observing	_
61-31	9655-9658	the	_
61-32	9659-9663	pain	_
61-33	9664-9666	of	_
61-34	9667-9674	another	_
61-35	9675-9676	.	_

Text=The defined ToM network was based on a meta-analysis of studies that involved taking the cognitive perspective of another ’ s mental state.
62-1	9677-9680	The	_
62-2	9681-9688	defined	_
62-3	9689-9692	ToM	_
62-4	9693-9700	network	_
62-5	9701-9704	was	_
62-6	9705-9710	based	_
62-7	9711-9713	on	_
62-8	9714-9715	a	_
62-9	9716-9729	meta-analysis	_
62-10	9730-9732	of	_
62-11	9733-9740	studies	_
62-12	9741-9745	that	_
62-13	9746-9754	involved	_
62-14	9755-9761	taking	_
62-15	9762-9765	the	_
62-16	9766-9775	cognitive	_
62-17	9776-9787	perspective	_
62-18	9788-9790	of	_
62-19	9791-9798	another	_
62-20	9799-9800	’	_
62-21	9801-9802	s	_
62-22	9803-9809	mental	_
62-23	9810-9815	state	_
62-24	9816-9817	.	_

Text=Seven regions were selected from the meta-analytical statistical map, and based on further evidence from another study as being the only regions reliability activated across various ToM tasks.
63-1	9818-9823	Seven	_
63-2	9824-9831	regions	_
63-3	9832-9836	were	_
63-4	9837-9845	selected	_
63-5	9846-9850	from	_
63-6	9851-9854	the	_
63-7	9855-9870	meta-analytical	_
63-8	9871-9882	statistical	_
63-9	9883-9886	map	_
63-10	9887-9888	,	_
63-11	9889-9892	and	_
63-12	9893-9898	based	_
63-13	9899-9901	on	_
63-14	9902-9909	further	_
63-15	9910-9918	evidence	_
63-16	9919-9923	from	_
63-17	9924-9931	another	_
63-18	9932-9937	study	_
63-19	9938-9940	as	_
63-20	9941-9946	being	_
63-21	9947-9950	the	_
63-22	9951-9955	only	_
63-23	9956-9963	regions	_
63-24	9964-9975	reliability	_
63-25	9976-9985	activated	_
63-26	9986-9992	across	_
63-27	9993-10000	various	_
63-28	10001-10004	ToM	_
63-29	10005-10010	tasks	_
63-30	10011-10012	.	_

Text=NCI analysis All NCI analyses were performed using a designated Matlab code, which will be made available upon request.
64-1	10013-10016	NCI	_
64-2	10017-10025	analysis	_
64-3	10026-10029	All	_
64-4	10030-10033	NCI	_
64-5	10034-10042	analyses	_
64-6	10043-10047	were	_
64-7	10048-10057	performed	_
64-8	10058-10063	using	_
64-9	10064-10065	a	_
64-10	10066-10076	designated	_
64-11	10077-10083	Matlab	_
64-12	10084-10088	code	_
64-13	10089-10090	,	_
64-14	10091-10096	which	_
64-15	10097-10101	will	_
64-16	10102-10104	be	_
64-17	10105-10109	made	_
64-18	10110-10119	available	_
64-19	10120-10124	upon	_
64-20	10125-10132	request	_
64-21	10133-10134	.	_

Text=In short, NCI analysis (Fig.
65-1	10135-10137	In	_
65-2	10138-10143	short	_
65-3	10144-10145	,	_
65-4	10146-10149	NCI	_
65-5	10150-10158	analysis	_
65-6	10159-10160	(	_
65-7	10161-10164	Fig	_
65-8	10165-10166	.	_

Text=1b) is a sliding-window method to estimate the functional connectivity dynamics between and within networks during continuous paradigms.
66-1	10167-10169	1b	_
66-2	10170-10171	)	_
66-3	10172-10174	is	_
66-4	10175-10176	a	_
66-5	10177-10191	sliding-window	_
66-6	10192-10198	method	_
66-7	10199-10201	to	_
66-8	10202-10210	estimate	_
66-9	10211-10214	the	_
66-10	10215-10225	functional	_
66-11	10226-10238	connectivity	_
66-12	10239-10247	dynamics	_
66-13	10248-10255	between	_
66-14	10256-10259	and	_
66-15	10260-10266	within	_
66-16	10267-10275	networks	_
66-17	10276-10282	during	_
66-18	10283-10293	continuous	_
66-19	10294-10303	paradigms	_
66-20	10304-10305	.	_

Text=NCI is a t-statistic based on the pairwise correlations of network nodes.
67-1	10306-10309	NCI	_
67-2	10310-10312	is	_
67-3	10313-10314	a	_
67-4	10315-10326	t-statistic	_
67-5	10327-10332	based	_
67-6	10333-10335	on	_
67-7	10336-10339	the	_
67-8	10340-10348	pairwise	_
67-9	10349-10361	correlations	_
67-10	10362-10364	of	_
67-11	10365-10372	network	_
67-12	10373-10378	nodes	_
67-13	10379-10380	.	_

Text=It is sensitive to both the magnitude and variance of connectivity within the network, thus depicting cohesion between nodes.
68-1	10381-10383	It	_
68-2	10384-10386	is	_
68-3	10387-10396	sensitive	_
68-4	10397-10399	to	_
68-5	10400-10404	both	_
68-6	10405-10408	the	_
68-7	10409-10418	magnitude	_
68-8	10419-10422	and	_
68-9	10423-10431	variance	_
68-10	10432-10434	of	_
68-11	10435-10447	connectivity	_
68-12	10448-10454	within	_
68-13	10455-10458	the	_
68-14	10459-10466	network	_
68-15	10467-10468	,	_
68-16	10469-10473	thus	_
68-17	10474-10483	depicting	_
68-18	10484-10492	cohesion	_
68-19	10493-10500	between	_
68-20	10501-10506	nodes	_
68-21	10507-10508	.	_

Text=In previous works, NCI of specific networks of interest were found to covary with empathy and emotion reactivity indices, pointing to their capacity to affect network dynamics.
69-1	10509-10511	In	_
69-2	10512-10520	previous	_
69-3	10521-10526	works	_
69-4	10527-10528	,	_
69-5	10529-10532	NCI	_
69-6	10533-10535	of	_
69-7	10536-10544	specific	_
69-8	10545-10553	networks	_
69-9	10554-10556	of	_
69-10	10557-10565	interest	_
69-11	10566-10570	were	_
69-12	10571-10576	found	_
69-13	10577-10579	to	_
69-14	10580-10586	covary	_
69-15	10587-10591	with	_
69-16	10592-10599	empathy	_
69-17	10600-10603	and	_
69-18	10604-10611	emotion	_
69-19	10612-10622	reactivity	_
69-20	10623-10630	indices	_
69-21	10631-10632	,	_
69-22	10633-10641	pointing	_
69-23	10642-10644	to	_
69-24	10645-10650	their	_
69-25	10651-10659	capacity	_
69-26	10660-10662	to	_
69-27	10663-10669	affect	_
69-28	10670-10677	network	_
69-29	10678-10686	dynamics	_
69-30	10687-10688	.	_

Text=To compute NCI, we first extracted the signal for each of the network nodes.
70-1	10689-10691	To	_
70-2	10692-10699	compute	_
70-3	10700-10703	NCI	_
70-4	10704-10705	,	_
70-5	10706-10708	we	_
70-6	10709-10714	first	_
70-7	10715-10724	extracted	_
70-8	10725-10728	the	_
70-9	10729-10735	signal	_
70-10	10736-10739	for	_
70-11	10740-10744	each	_
70-12	10745-10747	of	_
70-13	10748-10751	the	_
70-14	10752-10759	network	_
70-15	10760-10765	nodes	_
70-16	10766-10767	.	_

Text=The node ’ s signal was defined as the average signal of the voxel clusters reported by the relevant meta-analysis.
71-1	10768-10771	The	_
71-2	10772-10776	node	_
71-3	10777-10778	’	_
71-4	10779-10780	s	_
71-5	10781-10787	signal	_
71-6	10788-10791	was	_
71-7	10792-10799	defined	_
71-8	10800-10802	as	_
71-9	10803-10806	the	_
71-10	10807-10814	average	_
71-11	10815-10821	signal	_
71-12	10822-10824	of	_
71-13	10825-10828	the	_
71-14	10829-10834	voxel	_
71-15	10835-10843	clusters	_
71-16	10844-10852	reported	_
71-17	10853-10855	by	_
71-18	10856-10859	the	_
71-19	10860-10868	relevant	_
71-20	10869-10882	meta-analysis	_
71-21	10883-10884	.	_

Text=For each network, time-window, and participant, the set of all pairwise Pearson correlations within the network was computed.
72-1	10885-10888	For	_
72-2	10889-10893	each	_
72-3	10894-10901	network	_
72-4	10902-10903	,	_
72-5	10904-10915	time-window	_
72-6	10916-10917	,	_
72-7	10918-10921	and	_
72-8	10922-10933	participant	_
72-9	10934-10935	,	_
72-10	10936-10939	the	_
72-11	10940-10943	set	_
72-12	10944-10946	of	_
72-13	10947-10950	all	_
72-14	10951-10959	pairwise	_
72-15	10960-10967	Pearson	_
72-16	10968-10980	correlations	_
72-17	10981-10987	within	_
72-18	10988-10991	the	_
72-19	10992-10999	network	_
72-20	11000-11003	was	_
72-21	11004-11012	computed	_
72-22	11013-11014	.	_

Text=The time-windows spanned over 30 s (10 TRs) according to previous evidence for the validity of using windows of this length.
73-1	11015-11018	The	_
73-2	11019-11031	time-windows	_
73-3	11032-11039	spanned	_
73-4	11040-11044	over	_
73-5	11045-11047	30	_
73-6	11048-11049	s	_
73-7	11050-11051	(	_
73-8	11052-11054	10	_
73-9	11055-11058	TRs	_
73-10	11059-11060	)	_
73-11	11061-11070	according	_
73-12	11071-11073	to	_
73-13	11074-11082	previous	_
73-14	11083-11091	evidence	_
73-15	11092-11095	for	_
73-16	11096-11099	the	_
73-17	11100-11108	validity	_
73-18	11109-11111	of	_
73-19	11112-11117	using	_
73-20	11118-11125	windows	_
73-21	11126-11128	of	_
73-22	11129-11133	this	_
73-23	11134-11140	length	_
73-24	11141-11142	.	_

Text=We examined successive time windows with 90% overlap.
74-1	11143-11145	We	_
74-2	11146-11154	examined	_
74-3	11155-11165	successive	_
74-4	11166-11170	time	_
74-5	11171-11178	windows	_
74-6	11179-11183	with	_
74-7	11184-11186	90	_
74-8	11187-11188	%	_
74-9	11189-11196	overlap	_
74-10	11197-11198	.	_

Text=NCI was computed as the t-statistic of a Student ’ s t-test with a null hypothesis of µR = 0, performed on the Fisher z transformed coefficients for each participant, network, and time-window.
75-1	11199-11202	NCI	_
75-2	11203-11206	was	_
75-3	11207-11215	computed	_
75-4	11216-11218	as	_
75-5	11219-11222	the	_
75-6	11223-11234	t-statistic	_
75-7	11235-11237	of	_
75-8	11238-11239	a	_
75-9	11240-11247	Student	_
75-10	11248-11249	’	_
75-11	11250-11251	s	_
75-12	11252-11258	t-test	_
75-13	11259-11263	with	_
75-14	11264-11265	a	_
75-15	11266-11270	null	_
75-16	11271-11281	hypothesis	_
75-17	11282-11284	of	_
75-18	11285-11287	µR	_
75-19	11288-11289	=	_
75-20	11290-11291	0	_
75-21	11292-11293	,	_
75-22	11294-11303	performed	_
75-23	11304-11306	on	_
75-24	11307-11310	the	_
75-25	11311-11317	Fisher	_
75-26	11318-11319	z	_
75-27	11320-11331	transformed	_
75-28	11332-11344	coefficients	_
75-29	11345-11348	for	_
75-30	11349-11353	each	_
75-31	11354-11365	participant	_
75-32	11366-11367	,	_
75-33	11368-11375	network	_
75-34	11376-11377	,	_
75-35	11378-11381	and	_
75-36	11382-11393	time-window	_
75-37	11394-11395	.	_

Text=In this test, the t-statistic serves as a probe for the connectivity within the network, with elevated values when the mean correlation is high and variance is low.
76-1	11396-11398	In	_
76-2	11399-11403	this	_
76-3	11404-11408	test	_
76-4	11409-11410	,	_
76-5	11411-11414	the	_
76-6	11415-11426	t-statistic	_
76-7	11427-11433	serves	_
76-8	11434-11436	as	_
76-9	11437-11438	a	_
76-10	11439-11444	probe	_
76-11	11445-11448	for	_
76-12	11449-11452	the	_
76-13	11453-11465	connectivity	_
76-14	11466-11472	within	_
76-15	11473-11476	the	_
76-16	11477-11484	network	_
76-17	11485-11486	,	_
76-18	11487-11491	with	_
76-19	11492-11500	elevated	_
76-20	11501-11507	values	_
76-21	11508-11512	when	_
76-22	11513-11516	the	_
76-23	11517-11521	mean	_
76-24	11522-11533	correlation	_
76-25	11534-11536	is	_
76-26	11537-11541	high	_
76-27	11542-11545	and	_
76-28	11546-11554	variance	_
76-29	11555-11557	is	_
76-30	11558-11561	low	_
76-31	11562-11563	.	_

Text=Correlation of NCI with fear rating group difference We next investigated whether the difference between the fear ratings of schizophrenia patients and healthy controls were related to the corresponding inter-group difference in the connectivity of the ES and ToM networks.
77-1	11564-11575	Correlation	_
77-2	11576-11578	of	_
77-3	11579-11582	NCI	http://maven.renci.org/NeuroBridge/neurobridge#ThyroidCancer
77-4	11583-11587	with	_
77-5	11588-11592	fear	_
77-6	11593-11599	rating	_
77-7	11600-11605	group	_
77-8	11606-11616	difference	_
77-9	11617-11619	We	_
77-10	11620-11624	next	_
77-11	11625-11637	investigated	_
77-12	11638-11645	whether	_
77-13	11646-11649	the	_
77-14	11650-11660	difference	_
77-15	11661-11668	between	_
77-16	11669-11672	the	_
77-17	11673-11677	fear	_
77-18	11678-11685	ratings	_
77-19	11686-11688	of	_
77-20	11689-11702	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
77-21	11703-11711	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
77-22	11712-11715	and	_
77-23	11716-11723	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
77-24	11724-11732	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
77-25	11733-11737	were	_
77-26	11738-11745	related	_
77-27	11746-11748	to	_
77-28	11749-11752	the	_
77-29	11753-11766	corresponding	_
77-30	11767-11778	inter-group	_
77-31	11779-11789	difference	_
77-32	11790-11792	in	_
77-33	11793-11796	the	_
77-34	11797-11809	connectivity	_
77-35	11810-11812	of	_
77-36	11813-11816	the	_
77-37	11817-11819	ES	_
77-38	11820-11823	and	_
77-39	11824-11827	ToM	_
77-40	11828-11836	networks	_
77-41	11837-11838	.	_

Text=To examine the temporal relations between these parameters, we computed cross-correlations between NCI and the difference in rating indices, while displacing one time series relative to the other.
78-1	11839-11841	To	_
78-2	11842-11849	examine	_
78-3	11850-11853	the	_
78-4	11854-11862	temporal	_
78-5	11863-11872	relations	_
78-6	11873-11880	between	_
78-7	11881-11886	these	_
78-8	11887-11897	parameters	_
78-9	11898-11899	,	_
78-10	11900-11902	we	_
78-11	11903-11911	computed	_
78-12	11912-11930	cross-correlations	_
78-13	11931-11938	between	_
78-14	11939-11942	NCI	_
78-15	11943-11946	and	_
78-16	11947-11950	the	_
78-17	11951-11961	difference	_
78-18	11962-11964	in	_
78-19	11965-11971	rating	_
78-20	11972-11979	indices	_
78-21	11980-11981	,	_
78-22	11982-11987	while	_
78-23	11988-11998	displacing	_
78-24	11999-12002	one	_
78-25	12003-12007	time	_
78-26	12008-12014	series	_
78-27	12015-12023	relative	_
78-28	12024-12026	to	_
78-29	12027-12030	the	_
78-30	12031-12036	other	_
78-31	12037-12038	.	_

Text=To fit the rating index with the sliding-window format used for NCI analysis, the data was first down-sampled to 30 s windows.
79-1	12039-12041	To	_
79-2	12042-12045	fit	_
79-3	12046-12049	the	_
79-4	12050-12056	rating	_
79-5	12057-12062	index	_
79-6	12063-12067	with	_
79-7	12068-12071	the	_
79-8	12072-12086	sliding-window	_
79-9	12087-12093	format	_
79-10	12094-12098	used	_
79-11	12099-12102	for	_
79-12	12103-12106	NCI	_
79-13	12107-12115	analysis	_
79-14	12116-12117	,	_
79-15	12118-12121	the	_
79-16	12122-12126	data	_
79-17	12127-12130	was	_
79-18	12131-12136	first	_
79-19	12137-12149	down-sampled	_
79-20	12150-12152	to	_
79-21	12153-12155	30	_
79-22	12156-12157	s	_
79-23	12158-12165	windows	_
79-24	12166-12167	.	_

Text=In each time-window we performed a non-parametric Wilcoxon test to compare the median rating of the schizophrenia and healthy control groups.
80-1	12168-12170	In	_
80-2	12171-12175	each	_
80-3	12176-12187	time-window	_
80-4	12188-12190	we	_
80-5	12191-12200	performed	_
80-6	12201-12202	a	_
80-7	12203-12217	non-parametric	_
80-8	12218-12226	Wilcoxon	_
80-9	12227-12231	test	_
80-10	12232-12234	to	_
80-11	12235-12242	compare	_
80-12	12243-12246	the	_
80-13	12247-12253	median	_
80-14	12254-12260	rating	_
80-15	12261-12263	of	_
80-16	12264-12267	the	_
80-17	12268-12281	schizophrenia	_
80-18	12282-12285	and	_
80-19	12286-12293	healthy	_
80-20	12294-12301	control	_
80-21	12302-12308	groups	_
80-22	12309-12310	.	_

Text=A corresponding index for the inter-group NCI difference was similarly computed via a Wilcoxon test for the ES and ToM networks.
81-1	12311-12312	A	_
81-2	12313-12326	corresponding	_
81-3	12327-12332	index	_
81-4	12333-12336	for	_
81-5	12337-12340	the	_
81-6	12341-12352	inter-group	_
81-7	12353-12356	NCI	_
81-8	12357-12367	difference	_
81-9	12368-12371	was	_
81-10	12372-12381	similarly	_
81-11	12382-12390	computed	_
81-12	12391-12394	via	_
81-13	12395-12396	a	_
81-14	12397-12405	Wilcoxon	_
81-15	12406-12410	test	_
81-16	12411-12414	for	_
81-17	12415-12418	the	_
81-18	12419-12421	ES	_
81-19	12422-12425	and	_
81-20	12426-12429	ToM	_
81-21	12430-12438	networks	_
81-22	12439-12440	.	_

Text=The resulting Z-statistic time series were cross-correlated, as the NCI time-series were displaced relative to the rating difference series in a range of ±one time window with a single time point (one TR) lag (i.e., the NCI signal was shifted in up to ±10 TRs relative to the rating; see Fig.
82-1	12441-12444	The	_
82-2	12445-12454	resulting	_
82-3	12455-12466	Z-statistic	_
82-4	12467-12471	time	_
82-5	12472-12478	series	_
82-6	12479-12483	were	_
82-7	12484-12500	cross-correlated	_
82-8	12501-12502	,	_
82-9	12503-12505	as	_
82-10	12506-12509	the	_
82-11	12510-12513	NCI	_
82-12	12514-12525	time-series	_
82-13	12526-12530	were	_
82-14	12531-12540	displaced	_
82-15	12541-12549	relative	_
82-16	12550-12552	to	_
82-17	12553-12556	the	_
82-18	12557-12563	rating	_
82-19	12564-12574	difference	_
82-20	12575-12581	series	_
82-21	12582-12584	in	_
82-22	12585-12586	a	_
82-23	12587-12592	range	_
82-24	12593-12595	of	_
82-25	12596-12600	±one	_
82-26	12601-12605	time	_
82-27	12606-12612	window	_
82-28	12613-12617	with	_
82-29	12618-12619	a	_
82-30	12620-12626	single	_
82-31	12627-12631	time	_
82-32	12632-12637	point	_
82-33	12638-12639	(	_
82-34	12640-12643	one	_
82-35	12644-12646	TR	_
82-36	12647-12648	)	_
82-37	12649-12652	lag	_
82-38	12653-12654	(	_
82-39	12655-12659	i.e.	_
82-40	12660-12661	,	_
82-41	12662-12665	the	_
82-42	12666-12669	NCI	_
82-43	12670-12676	signal	_
82-44	12677-12680	was	_
82-45	12681-12688	shifted	_
82-46	12689-12691	in	_
82-47	12692-12694	up	_
82-48	12695-12697	to	_
82-49	12698-12701	±10	_
82-50	12702-12705	TRs	_
82-51	12706-12714	relative	_
82-52	12715-12717	to	_
82-53	12718-12721	the	_
82-54	12722-12728	rating	_
82-55	12729-12730	;	_
82-56	12731-12734	see	_
82-57	12735-12738	Fig	_
82-58	12739-12740	.	_

Text=S1).
83-1	12741-12743	S1	_
83-2	12744-12745	)	_
83-3	12746-12747	.	_

Text=This procedure yielded 21 NCI time courses (the non-shifted time series + 10 backward and forward shifted time courses) with 131 time-points each according to the following calculation (see Fig.
84-1	12748-12752	This	_
84-2	12753-12762	procedure	_
84-3	12763-12770	yielded	_
84-4	12771-12773	21	_
84-5	12774-12777	NCI	_
84-6	12778-12782	time	_
84-7	12783-12790	courses	_
84-8	12791-12792	(	_
84-9	12793-12796	the	_
84-10	12797-12808	non-shifted	_
84-11	12809-12813	time	_
84-12	12814-12820	series	_
84-13	12821-12822	+	_
84-14	12823-12825	10	_
84-15	12826-12834	backward	_
84-16	12835-12838	and	_
84-17	12839-12846	forward	_
84-18	12847-12854	shifted	_
84-19	12855-12859	time	_
84-20	12860-12867	courses	_
84-21	12868-12869	)	_
84-22	12870-12874	with	_
84-23	12875-12878	131	_
84-24	12879-12890	time-points	_
84-25	12891-12895	each	_
84-26	12896-12905	according	_
84-27	12906-12908	to	_
84-28	12909-12912	the	_
84-29	12913-12922	following	_
84-30	12923-12934	calculation	_
84-31	12935-12936	(	_
84-32	12937-12940	see	_
84-33	12941-12944	Fig	_
84-34	12945-12946	.	_

Text=S1 for visualization): The duration of the movie clip was 165 TRs.
85-1	12947-12949	S1	_
85-2	12950-12953	for	_
85-3	12954-12967	visualization	_
85-4	12968-12969	)	_
85-5	12970-12971	:	_
85-6	12972-12975	The	_
85-7	12976-12984	duration	_
85-8	12985-12987	of	_
85-9	12988-12991	the	_
85-10	12992-12997	movie	_
85-11	12998-13002	clip	_
85-12	13003-13006	was	_
85-13	13007-13010	165	_
85-14	13011-13014	TRs	_
85-15	13015-13016	.	_

Text=As mentioned above, five TRs were discarded from the data to avoid the film onset effect.
86-1	13017-13019	As	_
86-2	13020-13029	mentioned	_
86-3	13030-13035	above	_
86-4	13036-13037	,	_
86-5	13038-13042	five	_
86-6	13043-13046	TRs	_
86-7	13047-13051	were	_
86-8	13052-13061	discarded	_
86-9	13062-13066	from	_
86-10	13067-13070	the	_
86-11	13071-13075	data	_
86-12	13076-13078	to	_
86-13	13079-13084	avoid	_
86-14	13085-13088	the	_
86-15	13089-13093	film	_
86-16	13094-13099	onset	_
86-17	13100-13106	effect	_
86-18	13107-13108	.	_

Text=For the time series of 160 TRs that were left after this trimming, we calculated 151 sliding NCI/rating time windows (10 TRs each).
87-1	13109-13112	For	_
87-2	13113-13116	the	_
87-3	13117-13121	time	_
87-4	13122-13128	series	_
87-5	13129-13131	of	_
87-6	13132-13135	160	_
87-7	13136-13139	TRs	_
87-8	13140-13144	that	_
87-9	13145-13149	were	_
87-10	13150-13154	left	_
87-11	13155-13160	after	_
87-12	13161-13165	this	_
87-13	13166-13174	trimming	_
87-14	13175-13176	,	_
87-15	13177-13179	we	_
87-16	13180-13190	calculated	_
87-17	13191-13194	151	_
87-18	13195-13202	sliding	_
87-19	13203-13213	NCI/rating	_
87-20	13214-13218	time	_
87-21	13219-13226	windows	_
87-22	13227-13228	(	_
87-23	13229-13231	10	_
87-24	13232-13235	TRs	_
87-25	13236-13240	each	_
87-26	13241-13242	)	_
87-27	13243-13244	.	_

Text=From this NCI time series of 151 TRs we then derived time series shifted in up to ±10 TRs.
88-1	13245-13249	From	_
88-2	13250-13254	this	_
88-3	13255-13258	NCI	_
88-4	13259-13263	time	_
88-5	13264-13270	series	_
88-6	13271-13273	of	_
88-7	13274-13277	151	_
88-8	13278-13281	TRs	_
88-9	13282-13284	we	_
88-10	13285-13289	then	_
88-11	13290-13297	derived	_
88-12	13298-13302	time	_
88-13	13303-13309	series	_
88-14	13310-13317	shifted	_
88-15	13318-13320	in	_
88-16	13321-13323	up	_
88-17	13324-13326	to	_
88-18	13327-13330	±10	_
88-19	13331-13334	TRs	_
88-20	13335-13336	.	_

Text=These shifted time series were generated in an identical size to allow proper comparison.
89-1	13337-13342	These	_
89-2	13343-13350	shifted	_
89-3	13351-13355	time	_
89-4	13356-13362	series	_
89-5	13363-13367	were	_
89-6	13368-13377	generated	_
89-7	13378-13380	in	_
89-8	13381-13383	an	_
89-9	13384-13393	identical	_
89-10	13394-13398	size	_
89-11	13399-13401	to	_
89-12	13402-13407	allow	_
89-13	13408-13414	proper	_
89-14	13415-13425	comparison	_
89-15	13426-13427	.	_

Text=Under these constrains, the maximal size of the shifted time series was 131 TRs.
90-1	13428-13433	Under	_
90-2	13434-13439	these	_
90-3	13440-13450	constrains	_
90-4	13451-13452	,	_
90-5	13453-13456	the	_
90-6	13457-13464	maximal	_
90-7	13465-13469	size	_
90-8	13470-13472	of	_
90-9	13473-13476	the	_
90-10	13477-13484	shifted	_
90-11	13485-13489	time	_
90-12	13490-13496	series	_
90-13	13497-13500	was	_
90-14	13501-13504	131	_
90-15	13505-13508	TRs	_
90-16	13509-13510	.	_

Text=Spearman ’ s correlation coefficients were computed for each of the lagged data sets; for 21 inter-group NCI and rating duplets with 131 time-points each.
91-1	13511-13519	Spearman	_
91-2	13520-13521	’	_
91-3	13522-13523	s	_
91-4	13524-13535	correlation	_
91-5	13536-13548	coefficients	_
91-6	13549-13553	were	_
91-7	13554-13562	computed	_
91-8	13563-13566	for	_
91-9	13567-13571	each	_
91-10	13572-13574	of	_
91-11	13575-13578	the	_
91-12	13579-13585	lagged	_
91-13	13586-13590	data	_
91-14	13591-13595	sets	_
91-15	13596-13597	;	_
91-16	13598-13601	for	_
91-17	13602-13604	21	_
91-18	13605-13616	inter-group	_
91-19	13617-13620	NCI	_
91-20	13621-13624	and	_
91-21	13625-13631	rating	_
91-22	13632-13639	duplets	_
91-23	13640-13644	with	_
91-24	13645-13648	131	_
91-25	13649-13660	time-points	_
91-26	13661-13665	each	_
91-27	13666-13667	.	_

Text=We determined the significance of the correlations by applying a bootstrapping procedure that included phase randomization for each Fourier component of the individual NCI time series and then the inverse Fourier transformation.
92-1	13668-13670	We	_
92-2	13671-13681	determined	_
92-3	13682-13685	the	_
92-4	13686-13698	significance	_
92-5	13699-13701	of	_
92-6	13702-13705	the	_
92-7	13706-13718	correlations	_
92-8	13719-13721	by	_
92-9	13722-13730	applying	_
92-10	13731-13732	a	_
92-11	13733-13746	bootstrapping	_
92-12	13747-13756	procedure	_
92-13	13757-13761	that	_
92-14	13762-13770	included	_
92-15	13771-13776	phase	_
92-16	13777-13790	randomization	_
92-17	13791-13794	for	_
92-18	13795-13799	each	_
92-19	13800-13807	Fourier	_
92-20	13808-13817	component	_
92-21	13818-13820	of	_
92-22	13821-13824	the	_
92-23	13825-13835	individual	_
92-24	13836-13839	NCI	_
92-25	13840-13844	time	_
92-26	13845-13851	series	_
92-27	13852-13855	and	_
92-28	13856-13860	then	_
92-29	13861-13864	the	_
92-30	13865-13872	inverse	_
92-31	13873-13880	Fourier	_
92-32	13881-13895	transformation	_
92-33	13896-13897	.	_

Text=To control for 21 comparisons for each of the two main hypotheses (ToM-NCI rating and ES-NCI rating associations), we applied false discovery rate (FDR) for independent or positively dependent tests.
93-1	13898-13900	To	_
93-2	13901-13908	control	_
93-3	13909-13912	for	_
93-4	13913-13915	21	_
93-5	13916-13927	comparisons	_
93-6	13928-13931	for	_
93-7	13932-13936	each	_
93-8	13937-13939	of	_
93-9	13940-13943	the	_
93-10	13944-13947	two	_
93-11	13948-13952	main	_
93-12	13953-13963	hypotheses	_
93-13	13964-13965	(	_
93-14	13966-13973	ToM-NCI	_
93-15	13974-13980	rating	_
93-16	13981-13984	and	_
93-17	13985-13991	ES-NCI	_
93-18	13992-13998	rating	_
93-19	13999-14011	associations	_
93-20	14012-14013	)	_
93-21	14014-14015	,	_
93-22	14016-14018	we	_
93-23	14019-14026	applied	_
93-24	14027-14032	false	_
93-25	14033-14042	discovery	_
93-26	14043-14047	rate	_
93-27	14048-14049	(	_
93-28	14050-14053	FDR	_
93-29	14054-14055	)	_
93-30	14056-14059	for	_
93-31	14060-14071	independent	_
93-32	14072-14074	or	_
93-33	14075-14085	positively	_
93-34	14086-14095	dependent	_
93-35	14096-14101	tests	_
93-36	14102-14103	.	_

Text=Comparing NCI between groups We further examined whether significant NCI differences between schizophrenia patients and healthy controls can be found at specific time-windows during the movie.
94-1	14104-14113	Comparing	_
94-2	14114-14117	NCI	_
94-3	14118-14125	between	_
94-4	14126-14132	groups	_
94-5	14133-14135	We	_
94-6	14136-14143	further	_
94-7	14144-14152	examined	_
94-8	14153-14160	whether	_
94-9	14161-14172	significant	_
94-10	14173-14176	NCI	_
94-11	14177-14188	differences	_
94-12	14189-14196	between	_
94-13	14197-14210	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
94-14	14211-14219	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
94-15	14220-14223	and	_
94-16	14224-14231	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
94-17	14232-14240	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
94-18	14241-14244	can	_
94-19	14245-14247	be	_
94-20	14248-14253	found	_
94-21	14254-14256	at	_
94-22	14257-14265	specific	_
94-23	14266-14278	time-windows	_
94-24	14279-14285	during	_
94-25	14286-14289	the	_
94-26	14290-14295	movie	_
94-27	14296-14297	.	_

Text=To compare network connectivity between the groups, a two-sided Wilcoxon test was performed on the two distributions of individual NCI values for each of the networks.
95-1	14298-14300	To	_
95-2	14301-14308	compare	_
95-3	14309-14316	network	_
95-4	14317-14329	connectivity	_
95-5	14330-14337	between	_
95-6	14338-14341	the	_
95-7	14342-14348	groups	_
95-8	14349-14350	,	_
95-9	14351-14352	a	_
95-10	14353-14362	two-sided	_
95-11	14363-14371	Wilcoxon	_
95-12	14372-14376	test	_
95-13	14377-14380	was	_
95-14	14381-14390	performed	_
95-15	14391-14393	on	_
95-16	14394-14397	the	_
95-17	14398-14401	two	_
95-18	14402-14415	distributions	_
95-19	14416-14418	of	_
95-20	14419-14429	individual	_
95-21	14430-14433	NCI	_
95-22	14434-14440	values	_
95-23	14441-14444	for	_
95-24	14445-14449	each	_
95-25	14450-14452	of	_
95-26	14453-14456	the	_
95-27	14457-14465	networks	_
95-28	14466-14467	.	_

Text=This test was repeated for each of the time-windows.
96-1	14468-14472	This	_
96-2	14473-14477	test	_
96-3	14478-14481	was	_
96-4	14482-14490	repeated	_
96-5	14491-14494	for	_
96-6	14495-14499	each	_
96-7	14500-14502	of	_
96-8	14503-14506	the	_
96-9	14507-14519	time-windows	_
96-10	14520-14521	.	_

Text=To control for multiple comparisons, FDR correction was applied considering the total number of comparisons for each network (131 comparisons).
97-1	14522-14524	To	_
97-2	14525-14532	control	_
97-3	14533-14536	for	_
97-4	14537-14545	multiple	_
97-5	14546-14557	comparisons	_
97-6	14558-14559	,	_
97-7	14560-14563	FDR	_
97-8	14564-14574	correction	_
97-9	14575-14578	was	_
97-10	14579-14586	applied	_
97-11	14587-14598	considering	_
97-12	14599-14602	the	_
97-13	14603-14608	total	_
97-14	14609-14615	number	_
97-15	14616-14618	of	_
97-16	14619-14630	comparisons	_
97-17	14631-14634	for	_
97-18	14635-14639	each	_
97-19	14640-14647	network	_
97-20	14648-14649	(	_
97-21	14650-14653	131	_
97-22	14654-14665	comparisons	_
97-23	14666-14667	)	_
97-24	14668-14669	.	_

Text=We further examined whether differences between the groups are specifically related to the network connectivity or could also be found when comparing the time series of the BOLD amplitudes of these networks.
98-1	14670-14672	We	_
98-2	14673-14680	further	_
98-3	14681-14689	examined	_
98-4	14690-14697	whether	_
98-5	14698-14709	differences	_
98-6	14710-14717	between	_
98-7	14718-14721	the	_
98-8	14722-14728	groups	_
98-9	14729-14732	are	_
98-10	14733-14745	specifically	_
98-11	14746-14753	related	_
98-12	14754-14756	to	_
98-13	14757-14760	the	_
98-14	14761-14768	network	_
98-15	14769-14781	connectivity	_
98-16	14782-14784	or	_
98-17	14785-14790	could	_
98-18	14791-14795	also	_
98-19	14796-14798	be	_
98-20	14799-14804	found	_
98-21	14805-14809	when	_
98-22	14810-14819	comparing	_
98-23	14820-14823	the	_
98-24	14824-14828	time	_
98-25	14829-14835	series	_
98-26	14836-14838	of	_
98-27	14839-14842	the	_
98-28	14843-14847	BOLD	_
98-29	14848-14858	amplitudes	_
98-30	14859-14861	of	_
98-31	14862-14867	these	_
98-32	14868-14876	networks	_
98-33	14877-14878	.	_

Text=Thus, we averaged the Z-scored signals obtained for all of the network nodes, averaged the signals again using a sliding windows of 10 TRs and compared the resulting time series between the groups using a two-sided Wilcoxon test.
99-1	14879-14883	Thus	_
99-2	14884-14885	,	_
99-3	14886-14888	we	_
99-4	14889-14897	averaged	_
99-5	14898-14901	the	_
99-6	14902-14910	Z-scored	_
99-7	14911-14918	signals	_
99-8	14919-14927	obtained	_
99-9	14928-14931	for	_
99-10	14932-14935	all	_
99-11	14936-14938	of	_
99-12	14939-14942	the	_
99-13	14943-14950	network	_
99-14	14951-14956	nodes	_
99-15	14957-14958	,	_
99-16	14959-14967	averaged	_
99-17	14968-14971	the	_
99-18	14972-14979	signals	_
99-19	14980-14985	again	_
99-20	14986-14991	using	_
99-21	14992-14993	a	_
99-22	14994-15001	sliding	_
99-23	15002-15009	windows	_
99-24	15010-15012	of	_
99-25	15013-15015	10	_
99-26	15016-15019	TRs	_
99-27	15020-15023	and	_
99-28	15024-15032	compared	_
99-29	15033-15036	the	_
99-30	15037-15046	resulting	_
99-31	15047-15051	time	_
99-32	15052-15058	series	_
99-33	15059-15066	between	_
99-34	15067-15070	the	_
99-35	15071-15077	groups	_
99-36	15078-15083	using	_
99-37	15084-15085	a	_
99-38	15086-15095	two-sided	_
99-39	15096-15104	Wilcoxon	_
99-40	15105-15109	test	_
99-41	15110-15111	.	_

Text=Correlating NCIs with schizophrenia symptoms We next examined the co-variation between the network connectivity indices and the severity of schizophrenia symptoms.
100-1	15112-15123	Correlating	_
100-2	15124-15128	NCIs	_
100-3	15129-15133	with	_
100-4	15134-15147	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
100-5	15148-15156	symptoms	_
100-6	15157-15159	We	_
100-7	15160-15164	next	_
100-8	15165-15173	examined	_
100-9	15174-15177	the	_
100-10	15178-15190	co-variation	_
100-11	15191-15198	between	_
100-12	15199-15202	the	_
100-13	15203-15210	network	_
100-14	15211-15223	connectivity	_
100-15	15224-15231	indices	_
100-16	15232-15235	and	_
100-17	15236-15239	the	_
100-18	15240-15248	severity	_
100-19	15249-15251	of	_
100-20	15252-15265	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
100-21	15266-15274	symptoms	_
100-22	15275-15276	.	_

Text=We computed a Spearman correlation between the empathy-related NCIs and the positive, negative, and general Positive and Negative Syndrome Scale (PANSS) scores for each time-window throughout the movie.
101-1	15277-15279	We	_
101-2	15280-15288	computed	_
101-3	15289-15290	a	_
101-4	15291-15299	Spearman	_
101-5	15300-15311	correlation	_
101-6	15312-15319	between	_
101-7	15320-15323	the	_
101-8	15324-15339	empathy-related	_
101-9	15340-15344	NCIs	_
101-10	15345-15348	and	_
101-11	15349-15352	the	_
101-12	15353-15361	positive	_
101-13	15362-15363	,	_
101-14	15364-15372	negative	_
101-15	15373-15374	,	_
101-16	15375-15378	and	_
101-17	15379-15386	general	_
101-18	15387-15395	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-19	15396-15399	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-20	15400-15408	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-21	15409-15417	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-22	15418-15423	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-23	15424-15425	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-24	15426-15431	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-25	15432-15433	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
101-26	15434-15440	scores	_
101-27	15441-15444	for	_
101-28	15445-15449	each	_
101-29	15450-15461	time-window	_
101-30	15462-15472	throughout	_
101-31	15473-15476	the	_
101-32	15477-15482	movie	_
101-33	15483-15484	.	_

Text=FDR correction was applied to control for the total number of comparisons (131 comparisons) for each of the six main hypotheses (association between ES/ToM NCI and the positive, negative or general symptoms).
102-1	15485-15488	FDR	_
102-2	15489-15499	correction	_
102-3	15500-15503	was	_
102-4	15504-15511	applied	_
102-5	15512-15514	to	_
102-6	15515-15522	control	_
102-7	15523-15526	for	_
102-8	15527-15530	the	_
102-9	15531-15536	total	_
102-10	15537-15543	number	_
102-11	15544-15546	of	_
102-12	15547-15558	comparisons	_
102-13	15559-15560	(	_
102-14	15561-15564	131	_
102-15	15565-15576	comparisons	_
102-16	15577-15578	)	_
102-17	15579-15582	for	_
102-18	15583-15587	each	_
102-19	15588-15590	of	_
102-20	15591-15594	the	_
102-21	15595-15598	six	_
102-22	15599-15603	main	_
102-23	15604-15614	hypotheses	_
102-24	15615-15616	(	_
102-25	15617-15628	association	_
102-26	15629-15636	between	_
102-27	15637-15643	ES/ToM	_
102-28	15644-15647	NCI	_
102-29	15648-15651	and	_
102-30	15652-15655	the	_
102-31	15656-15664	positive	_
102-32	15665-15666	,	_
102-33	15667-15675	negative	_
102-34	15676-15678	or	_
102-35	15679-15686	general	_
102-36	15687-15695	symptoms	_
102-37	15696-15697	)	_
102-38	15698-15699	.	_

Text=Classification based on ToM and ES NCI In order to classify participants into their respective groups (Schizophrenia patients and healthy controls) we applied the k-nearest neighbor (KNN) classifier, which is a widely used machine learning classification algorithm based on the closest training examples in the feature space.
103-1	15700-15714	Classification	_
103-2	15715-15720	based	_
103-3	15721-15723	on	_
103-4	15724-15727	ToM	_
103-5	15728-15731	and	_
103-6	15732-15734	ES	_
103-7	15735-15738	NCI	_
103-8	15739-15741	In	_
103-9	15742-15747	order	_
103-10	15748-15750	to	_
103-11	15751-15759	classify	_
103-12	15760-15772	participants	_
103-13	15773-15777	into	_
103-14	15778-15783	their	_
103-15	15784-15794	respective	_
103-16	15795-15801	groups	_
103-17	15802-15803	(	_
103-18	15804-15817	Schizophrenia	_
103-19	15818-15826	patients	_
103-20	15827-15830	and	_
103-21	15831-15838	healthy	_
103-22	15839-15847	controls	_
103-23	15848-15849	)	_
103-24	15850-15852	we	_
103-25	15853-15860	applied	_
103-26	15861-15864	the	_
103-27	15865-15874	k-nearest	_
103-28	15875-15883	neighbor	_
103-29	15884-15885	(	_
103-30	15886-15889	KNN	_
103-31	15890-15891	)	_
103-32	15892-15902	classifier	_
103-33	15903-15904	,	_
103-34	15905-15910	which	_
103-35	15911-15913	is	_
103-36	15914-15915	a	_
103-37	15916-15922	widely	_
103-38	15923-15927	used	_
103-39	15928-15935	machine	_
103-40	15936-15944	learning	_
103-41	15945-15959	classification	_
103-42	15960-15969	algorithm	_
103-43	15970-15975	based	_
103-44	15976-15978	on	_
103-45	15979-15982	the	_
103-46	15983-15990	closest	_
103-47	15991-15999	training	_
103-48	16000-16008	examples	_
103-49	16009-16011	in	_
103-50	16012-16015	the	_
103-51	16016-16023	feature	_
103-52	16024-16029	space	_
103-53	16030-16031	.	_

Text=We used k = 10, and classification was carried out in the Matlab Classification Learner application (The MathWorks Inc., Natick, MA, USA).
104-1	16032-16034	We	_
104-2	16035-16039	used	_
104-3	16040-16041	k	_
104-4	16042-16043	=	_
104-5	16044-16046	10	_
104-6	16047-16048	,	_
104-7	16049-16052	and	_
104-8	16053-16067	classification	_
104-9	16068-16071	was	_
104-10	16072-16079	carried	_
104-11	16080-16083	out	_
104-12	16084-16086	in	_
104-13	16087-16090	the	_
104-14	16091-16097	Matlab	_
104-15	16098-16112	Classification	_
104-16	16113-16120	Learner	_
104-17	16121-16132	application	_
104-18	16133-16134	(	_
104-19	16135-16138	The	_
104-20	16139-16148	MathWorks	_
104-21	16149-16153	Inc.	_
104-22	16154-16155	,	_
104-23	16156-16162	Natick	_
104-24	16163-16164	,	_
104-25	16165-16167	MA	_
104-26	16168-16169	,	_
104-27	16170-16173	USA	_
104-28	16174-16175	)	_
104-29	16176-16177	.	_

Text=The NCI values per time point per network (simulation and ToM) were used as predictors (total of 302 features).
105-1	16178-16181	The	_
105-2	16182-16185	NCI	_
105-3	16186-16192	values	_
105-4	16193-16196	per	_
105-5	16197-16201	time	_
105-6	16202-16207	point	_
105-7	16208-16211	per	_
105-8	16212-16219	network	_
105-9	16220-16221	(	_
105-10	16222-16232	simulation	_
105-11	16233-16236	and	_
105-12	16237-16240	ToM	_
105-13	16241-16242	)	_
105-14	16243-16247	were	_
105-15	16248-16252	used	_
105-16	16253-16255	as	_
105-17	16256-16266	predictors	_
105-18	16267-16268	(	_
105-19	16269-16274	total	_
105-20	16275-16277	of	_
105-21	16278-16281	302	_
105-22	16282-16290	features	_
105-23	16291-16292	)	_
105-24	16293-16294	.	_

Text=We then assessed generalization through five-fold cross-validation.
106-1	16295-16297	We	_
106-2	16298-16302	then	_
106-3	16303-16311	assessed	_
106-4	16312-16326	generalization	_
106-5	16327-16334	through	_
106-6	16335-16344	five-fold	_
106-7	16345-16361	cross-validation	_
106-8	16362-16363	.	_

Text=The overall accuracy, sensitivity, specificity, and positive predictive value (PPV) was computed for each classifier; overall accuracy was the number of true classifications to total cohort; sensitivity was the number of true positives (i.e.
107-1	16364-16367	The	_
107-2	16368-16375	overall	_
107-3	16376-16384	accuracy	_
107-4	16385-16386	,	_
107-5	16387-16398	sensitivity	_
107-6	16399-16400	,	_
107-7	16401-16412	specificity	_
107-8	16413-16414	,	_
107-9	16415-16418	and	_
107-10	16419-16427	positive	_
107-11	16428-16438	predictive	_
107-12	16439-16444	value	_
107-13	16445-16446	(	_
107-14	16447-16450	PPV	_
107-15	16451-16452	)	_
107-16	16453-16456	was	_
107-17	16457-16465	computed	_
107-18	16466-16469	for	_
107-19	16470-16474	each	_
107-20	16475-16485	classifier	_
107-21	16486-16487	;	_
107-22	16488-16495	overall	_
107-23	16496-16504	accuracy	_
107-24	16505-16508	was	_
107-25	16509-16512	the	_
107-26	16513-16519	number	_
107-27	16520-16522	of	_
107-28	16523-16527	true	_
107-29	16528-16543	classifications	_
107-30	16544-16546	to	_
107-31	16547-16552	total	_
107-32	16553-16559	cohort	_
107-33	16560-16561	;	_
107-34	16562-16573	sensitivity	_
107-35	16574-16577	was	_
107-36	16578-16581	the	_
107-37	16582-16588	number	_
107-38	16589-16591	of	_
107-39	16592-16596	true	_
107-40	16597-16606	positives	_
107-41	16607-16608	(	_
107-42	16609-16612	i.e	_
107-43	16613-16614	.	_

Text=patients correctly classified) for the total number of patients; specificity was the number of true negatives (i.e.
108-1	16615-16623	patients	_
108-2	16624-16633	correctly	_
108-3	16634-16644	classified	_
108-4	16645-16646	)	_
108-5	16647-16650	for	_
108-6	16651-16654	the	_
108-7	16655-16660	total	_
108-8	16661-16667	number	_
108-9	16668-16670	of	_
108-10	16671-16679	patients	_
108-11	16680-16681	;	_
108-12	16682-16693	specificity	_
108-13	16694-16697	was	_
108-14	16698-16701	the	_
108-15	16702-16708	number	_
108-16	16709-16711	of	_
108-17	16712-16716	true	_
108-18	16717-16726	negatives	_
108-19	16727-16728	(	_
108-20	16729-16732	i.e	_
108-21	16733-16734	.	_

Text=healthy controls correctly classified) for the total number of healthy controls; positive predictive value (PPV) was the ratio of the true positives for all positive classifications (i.e.
109-1	16735-16742	healthy	_
109-2	16743-16751	controls	_
109-3	16752-16761	correctly	_
109-4	16762-16772	classified	_
109-5	16773-16774	)	_
109-6	16775-16778	for	_
109-7	16779-16782	the	_
109-8	16783-16788	total	_
109-9	16789-16795	number	_
109-10	16796-16798	of	_
109-11	16799-16806	healthy	_
109-12	16807-16815	controls	_
109-13	16816-16817	;	_
109-14	16818-16826	positive	_
109-15	16827-16837	predictive	_
109-16	16838-16843	value	_
109-17	16844-16845	(	_
109-18	16846-16849	PPV	_
109-19	16850-16851	)	_
109-20	16852-16855	was	_
109-21	16856-16859	the	_
109-22	16860-16865	ratio	_
109-23	16866-16868	of	_
109-24	16869-16872	the	_
109-25	16873-16877	true	_
109-26	16878-16887	positives	_
109-27	16888-16891	for	_
109-28	16892-16895	all	_
109-29	16896-16904	positive	_
109-30	16905-16920	classifications	_
109-31	16921-16922	(	_
109-32	16923-16926	i.e	_
109-33	16927-16928	.	_

Text=true and false positives).
110-1	16929-16933	true	_
110-2	16934-16937	and	_
110-3	16938-16943	false	_
110-4	16944-16953	positives	_
110-5	16954-16955	)	_
110-6	16956-16957	.	_

Text=Statistics were derived from the mean and standard deviation of all 1000 classifiers.
111-1	16958-16968	Statistics	_
111-2	16969-16973	were	_
111-3	16974-16981	derived	_
111-4	16982-16986	from	_
111-5	16987-16990	the	_
111-6	16991-16995	mean	_
111-7	16996-16999	and	_
111-8	17000-17008	standard	_
111-9	17009-17018	deviation	_
111-10	17019-17021	of	_
111-11	17022-17025	all	_
111-12	17026-17030	1000	_
111-13	17031-17042	classifiers	_
111-14	17043-17044	.	_

Text=For additional statistical significance assessment of the classification accuracy we conducted a bootstrapping procedure of permutation tests.
112-1	17045-17048	For	_
112-2	17049-17059	additional	_
112-3	17060-17071	statistical	_
112-4	17072-17084	significance	_
112-5	17085-17095	assessment	_
112-6	17096-17098	of	_
112-7	17099-17102	the	_
112-8	17103-17117	classification	_
112-9	17118-17126	accuracy	_
112-10	17127-17129	we	_
112-11	17130-17139	conducted	_
112-12	17140-17141	a	_
112-13	17142-17155	bootstrapping	_
112-14	17156-17165	procedure	_
112-15	17166-17168	of	_
112-16	17169-17180	permutation	_
112-17	17181-17186	tests	_
112-18	17187-17188	.	_

Text=The class labels of the original dataset were randomly permuted and then classified using the identical aforementioned KNN analysis procedure (using five-fold cross-validation and 1000 repetitions).
113-1	17189-17192	The	_
113-2	17193-17198	class	_
113-3	17199-17205	labels	_
113-4	17206-17208	of	_
113-5	17209-17212	the	_
113-6	17213-17221	original	_
113-7	17222-17229	dataset	_
113-8	17230-17234	were	_
113-9	17235-17243	randomly	_
113-10	17244-17252	permuted	_
113-11	17253-17256	and	_
113-12	17257-17261	then	_
113-13	17262-17272	classified	_
113-14	17273-17278	using	_
113-15	17279-17282	the	_
113-16	17283-17292	identical	_
113-17	17293-17307	aforementioned	_
113-18	17308-17311	KNN	_
113-19	17312-17320	analysis	_
113-20	17321-17330	procedure	_
113-21	17331-17332	(	_
113-22	17333-17338	using	_
113-23	17339-17348	five-fold	_
113-24	17349-17365	cross-validation	_
113-25	17366-17369	and	_
113-26	17370-17374	1000	_
113-27	17375-17386	repetitions	_
113-28	17387-17388	)	_
113-29	17389-17390	.	_

Text=This procedure was again repeated 1000 times.
114-1	17391-17395	This	_
114-2	17396-17405	procedure	_
114-3	17406-17409	was	_
114-4	17410-17415	again	_
114-5	17416-17424	repeated	_
114-6	17425-17429	1000	_
114-7	17430-17435	times	_
114-8	17436-17437	.	_

Text=The p-value of the permutation test was defined as the fraction of the number of permuted classifiers that obtained better classification accuracy than the original dataset, given aswhere k is the number of permutation tests (k = 1000).
115-1	17438-17441	The	_
115-2	17442-17449	p-value	_
115-3	17450-17452	of	_
115-4	17453-17456	the	_
115-5	17457-17468	permutation	_
115-6	17469-17473	test	_
115-7	17474-17477	was	_
115-8	17478-17485	defined	_
115-9	17486-17488	as	_
115-10	17489-17492	the	_
115-11	17493-17501	fraction	_
115-12	17502-17504	of	_
115-13	17505-17508	the	_
115-14	17509-17515	number	_
115-15	17516-17518	of	_
115-16	17519-17527	permuted	_
115-17	17528-17539	classifiers	_
115-18	17540-17544	that	_
115-19	17545-17553	obtained	_
115-20	17554-17560	better	_
115-21	17561-17575	classification	_
115-22	17576-17584	accuracy	_
115-23	17585-17589	than	_
115-24	17590-17593	the	_
115-25	17594-17602	original	_
115-26	17603-17610	dataset	_
115-27	17611-17612	,	_
115-28	17613-17618	given	_
115-29	17619-17626	aswhere	_
115-30	17627-17628	k	_
115-31	17629-17631	is	_
115-32	17632-17635	the	_
115-33	17636-17642	number	_
115-34	17643-17645	of	_
115-35	17646-17657	permutation	_
115-36	17658-17663	tests	_
115-37	17664-17665	(	_
115-38	17666-17667	k	_
115-39	17668-17669	=	_
115-40	17670-17674	1000	_
115-41	17675-17676	)	_
115-42	17677-17678	.	_

